Literature DB >> 32709069

LC-MS Lipidomics: Exploiting a Simple High-Throughput Method for the Comprehensive Extraction of Lipids in a Ruminant Fat Dose-Response Study.

Benjamin Jenkins1, Martin Ronis2, Albert Koulman1.   

Abstract

Typical lipidomics methods incorporate a liquid-liquid extraction with LC-MS quantitation; however, the classic sample extraction methods are not high-throughput and do not perform well at extracting the full range of lipids especially, the relatively polar species (e.g., acyl-carnitines and glycosphingolipids). In this manuscript, we present a novel sample extraction protocol, which produces a single phase supernatant suitable for high-throughput applications that offers greater performance in extracting lipids across the full spectrum of species. We applied this lipidomics pipeline to a ruminant fat dose-response study to initially compare and validate the different extraction protocols but also to investigate complex lipid biomarkers of ruminant fat intake (adjoining onto simple odd chain fatty acid correlations). We have found 100 lipids species with a strong correlation with ruminant fat intake. This novel sample extraction along with the LC-MS pipeline have shown to be sensitive, robust and hugely informative (>450 lipids species semi-quantified): with a sample preparation throughput of over 100 tissue samples per day and an estimated ~1000 biological fluid samples per day. Thus, this work facilitating both the epidemiological involvement of ruminant fat, research into odd chain lipids and also streamlining the field of lipidomics (both by sample preparation methods and data presentation).

Entities:  

Keywords:  Folch; lipid profiling; odd chain lipids; protein precipitation; relative lipid composition (Mol%); sample preparation

Year:  2020        PMID: 32709069      PMCID: PMC7407148          DOI: 10.3390/metabo10070296

Source DB:  PubMed          Journal:  Metabolites        ISSN: 2218-1989


1. Introduction

Lipids are generally understood as a class of molecules that have a high solubility in organic solvents and typically contain or originate from fatty acids. Although, lipids may be commonly derived, research has shown that there is a huge variety both structurally and functionally (potentially >40,000 [1]); where they play a vital role in energy production and storage [2,3], regulation and signalling [4,5], provide structure and support and membrane formation [6]. Lipids are now emerging as biomarkers of dietary/nutritional intakes [7] as well as indicators of pathophysiological status [8,9,10,11]. As a reaction of lipid-pathophysiological involvements, the field of lipidomics has emerged as a discipline that examines and quantifies a large proportion of the lipids present in a given sample set. Lipidomics requires an effective isolation protocol that comprehensively extracts lipids from the sample as well as an analytical method that allows their identification and quantitation. The typical analyte isolation protocols (with/without minor adaptations) that are often used in the literature include three different liquid–liquid extractions: Folch and colleagues [12] (cited >65,000 times), Bligh and Dyer [13] (cited >52,000 times) or Matyash and colleagues [14] (cited >1000 times). Although these extraction protocols are heavily cited and do result in adequate results, there are several caveats with their use. Firstly, there is the need to perform duplicate extraction in non-fluid samples to ensure optimal recovery of the lipid analytes. This is extremely time consuming, especially for the Folch and the Bligh and Dyer methods. Secondly, there are reasonable concerns that using a biphasic extraction (producing immiscible aqueous and organic phases) may result in a loss of relatively polar lipids (e.g., acyl-carnitines and gangliosides) into the disposed aqueous fractions (consisting of mostly methanol and water in these extraction protocols: Folch and the Bligh and Dyer). There are publications that use a single phase extraction protocol but they do not appear to solve the problem of extracting the relatively more polar lipids since a mixture of methanol, chloroform and tert-butyl methyl ether were used [15,16]. The technique overwhelmingly used tor analysing the lipidome is mass spectrometry hyphenated with chromatography (LC–MS) due to its sensitivity and selectivity; furthermore by using a high-resolution accurate mass instrument (e.g., Orbitrap or Time-of-Flight instruments), a huge number of analytes can be analysed simultaneously. Reversed phase chromatography is the predominant chromatographic technique employed to separate the analytes before entering the mass spectrometer to determine their structure and concentration. Variants of a liquid chromatography method utilising a C18-column with a water and acetonitrile mix for the weak eluting mobile phase and acetonitrile and propan-2-ol for the strong eluting mobile phase are the most commonly used [17,18,19,20,21,22]. These reversed phase C18-column methods both separate lipid based on their lipid class assignment (i.e., either phosphatidylcholines or phosphatidyethanolamines head group) and their fatty-acyl composition (i.e., chain length and degree of unsaturation) with some degree of isomeric separation. In this study, we present a lipidomics pipeline that including a novel analyte isolation protocol utilising a single phase, which results in a comprehensive lipid extraction suitable for a full range of lipid polarities (from polar to non-polar lipids species). This lipidomics method was tested, validated and then applied in a rat model investigating ruminant fat biomarkers via a beef tallow dose response dietary investigation.

2. Results

This lipidomics LC–MS method incorporating both of the described sample preparation protocols: protein precipitation (chloroform: methanol: acetone, ~7:3:4) and Folch liquid–liquid (chloroform: methanol: water, ~7:3:4), were utilised for the quantitation of lipids in liver samples from Sprague–Dawley rats who received one of four experimental diets overfed at 17% above matched growth. A comparison of the two sample preparation methods on the extraction of the stable isotope-labelled internal standards are shown in the figure below (see Figure 1). A comparison on the samples’ endogenous individual lipid classes are shown in the Supplementary Materials (see Supplementary Figure S1 and Table S1).
Figure 1

This figure shows the comparison between the two lipid extraction techniques regarding their extraction efficiency of the stable isotope internal standards from the rat liver samples (Folch liquid–liquid extraction: chloroform: methanol: water, ~7:3:4 , and Protein precipitation liquid extraction: chloroform: methanol: acetone, ~7:3:4 ). n = 34 rat liver samples per extraction method. The intensity of the internal standards were measured by liquid chromatography with mass spectrometry. The significance of the difference between the two extraction protocols are shown by the p-value star system; where p ≤ 0.05 was considered statistically significant (* p < 0.05, ** p < 0.01, *** p < 0.001). Error bars represent ± standard deviation. Lipid internal standard include: Butyryl-d7-L-carnitine (abbreviated to IS_Car_4:0-d7), N-tetradecylphosphocholine-d42 (abbreviated to IS_LPC_14:0-d42), hexadecanoyl-L-carnitine-d3 (abbreviated to IS_Car_16:0-d3), heptadecanoic-d33 acid (abbreviated to IS_FA_17:0-d33), 1,2-dimyristoyl-d54-sn-glycero-3-[phospho-L-serine] (abbreviated to IS_PS_28:0-d54), 1-palmitoyl-d31-2-oleoyl-sn-glycero-3-phosphoinositol (abbreviated to IS_PI_34:1-d31), N-palmitoyl-d31-D-erythro-sphingosylphosphorylcholine (abbreviated to IS_SM_34:1-d31), 1-palmitoyl-d31-2-oleoyl-sn-glycero-3-[phospho-rac-(1-glycerol)] (abbreviated to IS_PG_34:1-d31), 1-palmitoyl-d31-2-oleoyl-sn-glycero-3-phosphate (abbreviated to IS_PA_34:1-d31), N-palmitoyl-d31-D-erythro-sphingosine (abbreviated to IS_Cer_16:0-d31), 1-palmitoyl-d31-2-oleoyl-sn-glycero-3-phosphocholine (abbreviated to IS_PC_34:1-d31), 1-palmitoyl-d31-2-oleoyl-sn-glycero-3-phosphoethanolamine (abbreviated to IS_PE_34:1-d31), glyceryl tri(pentadecanoate-d29) (abbreviated to IS_TG_45:0-d87).

As shown the intensity of seven of the internal standards are statistically significantly higher in the protein precipitation protocol when compared to the Folch liquid–liquid protocol (between ~30% to ~2500% higher), whereas, only two of the internal standards were higher in the Folch liquid–liquid protocol (between ~20% and ~37% higher). Additionally, there is far less variation in the protein precipitation liquid extraction protocol: 10 out of 13 internal standards had ~2% to ~72% less variation in their coefficient of variation (CV). The protein precipitation liquid extraction protocol has also been shown to produce a significantly higher detection of the samples’ endogenous lipids, both producing a higher total number of lipid detected (Folch-LLE: 455 lipid species, PPLE: 472 lipid species) and a statistically significantly higher total intensity for twelve of the sixteen lipid classes detected (see Supplementary Figure S1 and Table S1). Taken as a whole, the protein precipitation protocol (chloroform: methanol: acetone, ~7:3:4) showed a greater extraction capability across the full lipid hydro-philicity/phobicity range and across the internal standards. Additionally, the high throughput of the protein precipitation protocol allows for over 100 tissue samples to be extracted per day (including dissection, weighing and tissue extraction ready for LC–MS analysis), whereas, the Folch liquid–liquid protocol could take up to three- to four-times longer due to the necessity of duplicate extractions and the delicacy of liquid–liquid phase separation. The throughput of the protein precipitation protocol (chloroform: methanol: acetone, ~7:3:4) on fluid samples allows an estimated ~1000 biological fluid sample extractions per day (including aliquoting, sample extraction ready for LC–MS analysis) when utilising basic laboratory fluid handling equipment/robots (throughput data not shown here). The liver lipid concentration (nM/mg) for each experimental diet group of rats are shown in the table below (see Table 1), along with the correlation (trendline equation, slope significance, R2 and successive change across the groups) of the measured lipid concentration with the percentage composition of ruminant fat (beef tallow) in each experimental diet. An R2 threshold of 0.75, slope significance p-value < 0.05 and successive increase/decrease were set to establish if there was a strong correlation between the lipid concentration and the ruminant fat composition.
Table 1

This table shows the liver lipid concentrations from the Sprague–Dawley rats who received one of four experimental diets (n = 8–9 per group). Diet 1: 50% corn oil, 16.4% MCT oil and 3.6% beef tallow; Diet 2: 35% corn oil, 28.7% MCT oil and 6.3% beef tallow; Diet 3: 20% corn oil, 41.0% MCT oil and 9.0% beef tallow; Diet 4: 5% corn oil, 53.3% MCT oil and 11.7% beef tallow. MCT: medium chain triglyceride oil. Lipid are shown in their shorthand notations with the number of carbons and unsaturated bonds in the fatty acid moiety separated by a colon; acyl-carnitines (Carn), ceramides (Cer), cardiolipins (CL), diacylglycerols (DG), gangliosides (GM1), hexosylceramides (Hex-Cer), lyso-phosphatidylcholines (LPC), lyso-phosphatidyethanolamines (LPE), lyso-phosphatidylinositols (LPI), lyso-cardiolipins (Lyso_CL), phosphatidic acids (PA), phosphatidylcholines (PC), phosphatidylethanolamines (PE), phosphatidylglycerol (PG), phosphatidylinositols (PI), phosphatidylserines (PS), sulfatides (S), sphingomyelins (SM), triacylglycerides (TG). Lipid concentrations (nM/mg) are shown as mean ± standard deviation and were extracted via the protein precipitation liquid extraction protocol (chloroform: methanol: acetone, ~7:3:4). Correlation between the ruminant fat composition of the diet and the lipid concentration are depicted by the trendline equation (* denotes statistical significance of the slope: p-value < 0.05) and coefficient of determination (R2). Lipid concentrations continually increasing/decreasing across the groups as the ruminant fat composition of the diet increase are emphasised in the ‘Successive change across group’ column. Lipids with a significant slope (p-value < 0.05) with an R2 greater than 0.75 and successively increasing/decreasing are in bold and highlighted.

Diet 1Diet 2Diet 3Diet 4Trendline EquationR2Successive Change Across Groups
Carn_(C00:0)99,100 ± 19,20090,200 ± 38,800126,000 ± 29,00092,400 ± 49,600y = 581x + 97,5000.02
Carn_(C02:0)10,400 ± 415010,700 ± 328012,900 ± 674011,700 ± 5300y = 226x + 97000.49
Carn_(C03:0) 3430 ± 1380 3590 ± 1820 3760 ± 2170 3830 ± 2240 y = 50.7x + 3260 * 0.97 Increasing
Carn_(C03:0-2COOH)713 ± 326436 ± 299943 ± 438700 ± 604y = 17.3x + 5650.08
Carn_(C03:0-OH)ND ± ND1.46 ± 4.392.1 ± 5.946.16 ± 13y = 0.87x − 4.590.85
Carn_(C03:1)108 ± 64.2105 ± 58.2101 ± 75.675.5 ± 35.3y = −3.76x + 1260.78Decreasing
Carn_(C04:0)1040 ± 847675 ± 3421560 ± 659793 ± 309y = 5.33x + 9760.00
Carn_(C04:0-OH)952 ± 429702 ± 5031730 ± 9441230 ± 619y = 69x + 6260.30
Carn_(C04:1)134 ± 56102 ± 94.489.6 ± 63.3104 ± 78.4y = −3.79x + 1360.49
Carn_(C05:0)490 ± 534359 ± 173857 ± 577553 ± 437y = 25.4x + 3700.18
Carn_(C05:1)319 ± 125255 ± 87.3317 ± 205227 ± 99.5y = −7.93x + 3400.36
Carn_(C06:0)324 ± 287183 ± 61.5635 ± 296234 ± 123y = 6.74x + 2920.01
Carn_(C06:0-2COOH)511 ± 145362 ± 124742 ± 246477 ± 213y = 10.3x + 4440.05
Carn_(C08:0)168 ± 174107 ± 66.6412 ± 185186 ± 215y = 13.3x + 1170.12
Carn_(C08:1)81.7 ± 50.9102 ± 56.5124 ± 54.888.3 ± 62.7y = 1.55x + 87.20.08
Carn_(C10:0-2COOH)353 ± 178361 ± 124378 ± 146296 ± 177y = −5.7x + 3910.31
Carn_(C12:0)0.265 ± 0.3390.147 ± 0.3530.495 ± 0.2910.412 ± 0.402y = 0.0292x + 0.1060.43
Carn_(C14:0)11.1 ± 6.529.39 ± 8.4814.8 ± 5.3613 ± 5.69y = 0.411x + 8.920.38
Carn_(C15:0)4.33 ± 2.643.76 ± 2.874.88 ± 1.523.65 ± 0.927y = −0.0341x + 4.420.04
Carn_(C16:0)618 ± 339457 ± 315739 ± 411462 ± 226y = −6.89x + 6220.03
Carn_(C16:0-OH)1.2 ± 1.561.52 ± 1.981.61 ± 1.352.46 ± 2.18y = 0.143x + 0.6010.86Increasing
Carn_(C16:2)9.89 ± 7.099.69 ± 4.497.61 ± 4.0110.9 ± 4.92y = 0.0352x + 9.250.01
Carn_(C17:0)19.2 ± 8.9313.9 ± 6.722.3 ± 9.0418.4 ± 7.41y = 0.222x + 16.80.05
Carn_(C18:0)627 ± 220541 ± 170656 ± 154620 ± 221y = 3.48x + 5840.06
Carn_(C18:0-OH)5.47 ± 3.316.8 ± 3.55.41 ± 4.188.14 ± 4.52y = 0.245x + 4.580.44
Carn_(C18:1)1530 ± 10901230 ± 9311900 ± 9581130 ± 449y = −19.6x + 16000.04
Carn_(C18:2)824 ± 754631 ± 525374 ± 157505 ± 259y = −45x + 9270.67
Carn_(C18:3)16.8 ± 16.414.7 ± 13.311.5 ± 6.3814.8 ± 5.16y = −0.341x + 17.10.29
Carn_(C20:0)43.1 ± 38.941.9 ± 28.232.5 ± 20.445.9 ± 22.9y = −0.037x + 41.10.00
Carn_(C22:5) 2.6 ± 3.13 2.34 ± 2.81 1.7 ± 1.25 1.66 ± 1.06 y = −0.128x + 3.06 * 0.91 Decreasing
Cer_(32:1)5.17 ± 1.264.31 ± 0.7835.34 ± 1.785.4 ± 1.75y = 0.0637x + 4.570.19
Cer_(33:1) 2.29 ± 1.92 1.68 ± 1.26 1.48 ± 0.544 1.27 ± 0.925 y = −0.121x + 2.6 * 0.92 Decreasing
Cer_(34:0)0.918 ± 0.571.19 ± 1.132.53 ± 2.191.93 ± 1.51y = 0.162x + 0.4020.60
Cer_(34:1)1.49 ± 0.5811.23 ± 0.8811.79 ± 1.012.56 ± 0.989y = 0.14x + 0.6990.71
Cer_(35:0)ND ± NDND ± ND0.0674 ± 0.191ND ± ND
Cer_(35:1) 1.03 ± 1.06 1.61 ± 1.06 1.63 ± 1.08 2.16 ± 1.45 y = 0.126x + 0.641 * 0.91 Increasing
Cer_(36:0) 7.26 ± 2.79 9.98 ± 5.3 10.5 ± 4.07 13.1 ± 2.89 y = 0.668x + 5.1 * 0.95 Increasing
Cer_(36:1)54.5 ± 26.255.4 ± 10.459.7 ± 16.371.7 ± 24.5y = 2.07x + 44.50.83Increasing
Cer_(36:2)6.59 ± 3.555.23 ± 1.185.94 ± 2.236.81 ± 3.13y = 0.0507x + 5.750.06
Cer_(37:1)2.23 ± 0.7671.9 ± 0.7232.31 ± 0.7724.23 ± 1.09y = 0.237x + 0.8510.61
Cer_(37:2)ND ± NDND ± ND0.066 ± 0.187ND ± ND
Cer_(38:0)2.14 ± 1.193.82 ± 3.782.1 ± 0.7152.9 ± 0.626y = 0.0207x + 2.580.01
Cer_(38:1)47.9 ± 18.834.1 ± 7.2139.5 ± 10.356 ± 13y = 1.1x + 360.16
Cer_(38:2)6.76 ± 3.874.76 ± 1.574.7 ± 0.9678.02 ± 1.98y = 0.138x + 5.010.09
Cer_(39:0)0.188 ± 0.08140.221 ± 0.1490.243 ± 0.1530.724 ± 0.454y = 0.0604x − 0.1180.68Increasing
Cer_(39:1)10.5 ± 3.448.36 ± 1.610.6 ± 1.6220.3 ± 3.17y = 1.17x + 3.480.58
Cer_(39:2)0.436 ± 0.4470.332 ± 0.3330.416 ± 0.3421.65 ± 0.755y = 0.138x − 0.3470.58
Cer_(40:0) 3.71 ± 0.85 4.12 ± 0.933 4.74 ± 1.44 6.17 ± 0.98 y = 0.296x + 2.42 * 0.92 Increasing
Cer_(40:1)126 ± 37.9116 ± 18.7146 ± 51227 ± 39.1y = 12.3x + 59.40.73
Cer_(40:2)65.5 ± 24.750.8 ± 8.263 ± 13.4105 ± 12.7y = 4.84x + 340.52
Cer_(41:0) 2.95 ± 0.547 3.91 ± 1.03 4.94 ± 1.2 7.37 ± 1.36 y = 0.529x + 0.744 * 0.94 Increasing
Cer_(41:1) 72.1 ± 18.6 89.7 ± 20.4 130 ± 88.3 210 ± 48.4 y = 16.8x − 3.18 * 0.91 Increasing
Cer_(41:2)51.4 ± 19.149.6 ± 11.463.3 ± 6.75144 ± 22.5y = 10.8x − 5.520.70
Cer_(42:0) 6.21 ± 2.01 8.11 ± 2.54 11.5 ± 5.17 12.2 ± 3.76 y = 0.791x + 3.45 * 0.95 Increasing
Cer_(42:1) 310 ± 63.3 444 ± 130 624 ± 539 773 ± 305 y = 58.1x + 93.2 * 1.00 Increasing
Cer_(42:2)575 ± 161599 ± 87.4721 ± 1201180 ± 187y = 71.7x + 2200.79Increasing
Cer_(42:3)105 ± 40.292 ± 19.5103 ± 26.1151 ± 16.5y = 5.52x + 70.50.54
Cer_(43:0) 1.31 ± 0.425 2.05 ± 0.699 2.43 ± 0.806 3.07 ± 0.982 y = 0.21x + 0.611 * 0.99 Increasing
Cer_(43:1) 131 ± 31.2 218 ± 62.9 253 ± 87.4 396 ± 111 y = 30.7x + 14.3 * 0.94 Increasing
Cer_(43:2)42.9 ± 7.6258.9 ± 11.964.2 ± 12.8115 ± 17.2y = 8.21x + 7.460.84Increasing
Cer_(44:1) 16.7 ± 4.31 28.5 ± 8.34 38.9 ± 26.1 43 ± 14.8 y = 3.31x + 6.47 * 0.96 Increasing
Cer_(44:2) 0.908 ± 0.271 1.19 ± 0.288 1.72 ± 1.08 2.08 ± 0.644 y = 0.15x + 0.328 * 0.99 Increasing
Cer_(45:1)0.46 ± 0.2151.19 ± 0.5311.32 ± 0.6181.58 ± 0.746y = 0.129x + 0.1490.88Increasing
Cer_(45:2)ND ± ND0.00348 ± 0.01040.00503 ± 0.0142ND ± NDy = 0.000574x − 0.0001371.00
Cer_(46:1) 0.0023 ± 0.0069 0.0192 ± 0.0266 0.0409 ± 0.0568 0.0568 ± 0.0824 y = 0.00686x − 0.0227 * 1.00 Increasing
Cer_(46:2)0.83 ± 0.1871.53 ± 0.4391.57 ± 0.5161.79 ± 0.679y = 0.108x + 0.6030.82Increasing
CL_(66:02) 8.65 ± 6.02 22.3 ± 17.1 32.3 ± 17.1 37.7 ± 31.3 y = 3.6x − 2.29 * 0.97 Increasing
CL_(66:03)15.8 ± 10.123.6 ± 16.424.2 ± 13.217.3 ± 8.8y = 0.189x + 18.80.02
CL_(66:04)15.5 ± 10.721.8 ± 10.429.7 ± 16.727 ± 15.3y = 1.57x + 11.50.76
CL_(66:05) 40.5 ± 20 39.1 ± 10.7 18.5 ± 10.3 1 ± 0.911 y = −5.15x + 64.2 * 0.92 Decreasing
CL_(66:06)66.1 ± 3767.9 ± 26.465.1 ± 38.122.6 ± 13.2y = −4.94x + 93.20.62
CL_(67:02)4.6 ± 5.8815.8 ± 13.311.3 ± 6.0210.1 ± 10y = 0.444x + 7.050.11
CL_(67:03)13.4 ± 9.8522.4 ± 1414.1 ± 6.365.97 ± 4.69y = −1.13x + 22.60.35
CL_(67:05) 0.848 ± 1.74 1.4 ± 2.57 2.58 ± 2.02 3.16 ± 1.62 y = 0.301x − 0.303 * 0.98 Increasing
CL_(68:00)0.484 ± 0.5020.898 ± 1.10.998 ± 1.120.519 ± 1.01y = 0.00759x + 0.6670.01
CL_(68:01)105 ± 91.1260 ± 222190 ± 107142 ± 163y = 1.52x + 1630.01
CL_(68:02)469 ± 3851010 ± 799664 ± 355434 ± 480y = −16.7x + 7720.05
CL_(68:03)631 ± 4211030 ± 670560 ± 261237 ± 199y = −61.2x + 10800.43
CL_(68:04)367 ± 179439 ± 197294 ± 113184 ± 112y = −25.7x + 5180.68
CL_(69:04)40.4 ± 31.966.9 ± 41.756.3 ± 27.328.8 ± 18.6y = −1.68x + 610.12
CL_(69:05)64.8 ± 37.567.7 ± 29.751.2 ± 20.431.1 ± 15.2y = −4.36x + 870.83
CL_(69:06)49.7 ± 32.349.7 ± 20.529.3 ± 1125.1 ± 10.8y = −3.49x + 65.10.86
CL_(69:07)0.245 ± 0.7361.06 ± 0.9421.33 ± 1.170.685 ± 0.79y = 0.0589x + 0.380.19
CL_(70:01)1.45 ± 1.876.38 ± 7.094.32 ± 2.943.91 ± 5.53y = 0.197x + 2.510.12
CL_(70:02)61.2 ± 59.7102 ± 90.154.6 ± 31.233.4 ± 40.7y = −4.84x + 99.90.35
CL_(70:03)470 ± 379796 ± 600559 ± 271340 ± 303y = −23.2x + 7190.18
CL_(70:04)1270 ± 8142010 ± 13001510 ± 656950 ± 761y = −54.1x + 18500.18
CL_(70:05)1770 ± 8892210 ± 10601670 ± 6411200 ± 780y = −83.3x + 23500.49
CL_(70:06)1280 ± 6291570 ± 5951560 ± 6881440 ± 897y = 17.4x + 13300.20
CL_(70:07)882 ± 4801110 ± 3991210 ± 657971 ± 551y = 13.6x + 9390.11
CL_(70:08) 256 ± 199 245 ± 108 147 ± 56.7 89.7 ± 52.6 y = −22.1x + 354 * 0.93 Decreasing
CL_(70:09)25.8 ± 18.327.1 ± 13.617.7 ± 8.6214.1 ± 7.15y = −1.65x + 33.80.83
CL_(71:02)0.744 ± 1.362.59 ± 31.41 ± 1.380.451 ± 0.714y = −0.0763x + 1.880.08
CL_(71:03)7.35 ± 7.4520.2 ± 18.218.2 ± 119.9 ± 8.38y = 0.209x + 12.30.01
CL_(71:04)19.5 ± 12.751.1 ± 39.565.7 ± 41.943 ± 33y = 3.15x + 20.70.32
CL_(71:05)56.9 ± 35116 ± 76.6130 ± 56.9107 ± 69.8y = 6.09x + 55.90.44
CL_(71:06)106 ± 65.4164 ± 78.1192 ± 74.8164 ± 88.4y = 7.48x + 99.30.52
CL_(71:07)76.3 ± 55.8104 ± 37.6120 ± 42.8101 ± 54.8y = 3.34x + 74.80.41
CL_(71:08) 23.9 ± 25.3 17.1 ± 6.59 5.98 ± 4.09 0.44 ± 0.928 y = −3.02x + 34.9 * 0.98 Decreasing
CL_(72:01)0.251 ± 0.4411.36 ± 1.40.758 ± 0.6480.825 ± 1.56y = 0.0415x + 0.4810.10
CL_(72:02)0.874 ± 1.2910.3 ± 12.34.1 ± 2.734.24 ± 7.52y = 0.144x + 3.770.02
CL_(72:03)22.6 ± 21.755.2 ± 54.723.4 ± 12.217.9 ± 25y = −1.7x + 42.80.12
CL_(72:04)246 ± 202374 ± 291228 ± 110237 ± 229y = −6.41x + 3200.11
CL_(72:05)2310 ± 13003190 ± 17502650 ± 10802000 ± 1500y = −54.4x + 29500.14
CL_(72:06)10,800 ± 564012,200 ± 49509770 ± 36605820 ± 3810y = −643x + 14,6000.67
CL_(72:07) 28,500 ± 15,500 25,400 ± 6760 17,100 ± 6180 7210 ± 4430 y = −2670x + 40,000 * 0.96 Decreasing
CL_(72:08) 31,100 ± 17,500 24,200 ± 5090 13,800 ± 4820 4420 ± 2860 y = −3350x + 44,000 * 0.99 Decreasing
CL_(72:09) 1280 ± 774 1150 ± 378 798 ± 339 456 ± 284 y = −105x + 1720 * 0.97 Decreasing
CL_(72:10)66.9 ± 45.262.8 ± 21.462 ± 40.570.8 ± 37.4y = 0.404x + 62.50.12
CL_(74:06) 1080 ± 745 930 ± 448 489 ± 203 395 ± 366 y = −92.4x + 1430 * 0.94 Decreasing
CL_(74:07) 4550 ± 2900 3350 ± 1190 2000 ± 712 1650 ± 1280 y = −372x + 5740 * 0.95 Decreasing
CL_(74:08) 8200 ± 4930 6210 ± 1800 4510 ± 1460 3490 ± 2360 y = −586x + 10,100 * 0.98 Decreasing
CL_(74:09) 7180 ± 3960 6480 ± 1830 5090 ± 1530 3460 ± 2210 y = −465x + 9110 * 0.97 Decreasing
CL_(74:10) 3980 ± 2390 3050 ± 652 1860 ± 595 1030 ± 673 y = −372x + 5320 * 1.00 Decreasing
CL_(74:11) 1240 ± 707 784 ± 177 454 ± 136 284 ± 181 y = −118x + 1600 * 0.96 Decreasing
CL_(76:09)802 ± 495560 ± 202416 ± 152633 ± 566y = −24.1x + 7870.27
CL_(76:10)1300 ± 724974 ± 335723 ± 242960 ± 768y = −47.1x + 13500.48
CL_(76:11)1580 ± 8941140 ± 399678 ± 217710 ± 530y = −114x + 19000.87
CL_(76:12) 1200 ± 704 925 ± 337 513 ± 163 441 ± 328 y = −99.6x + 1530 * 0.94 Decreasing
DG_(32:0)194 ± 10864.5 ± 72.475.8 ± 12299.9 ± 108y = −10x + 1850.35
DG_(34:0)84.3 ± 16748.3 ± 145ND ± NDND ± NDy = -13.3x + 1321.00
DG_(34:1)6950 ± 45703290 ± 14203300 ± 16004690 ± 4060y = −251x + 64800.26
GM1_(34:0)1.47 ± 1.395.46 ± 4.454.11 ± 4.433.26 ± 2.36y = 0.149x + 2.440.10
GM1_(34:1)4.89 ± 3.7615.3 ± 11.110.6 ± 9.269.27 ± 6.24y = 0.313x + 7.620.06
GM1_(34:1-OH)0.054 ± 0.04510.0988 ± 0.09440.0491 ± 0.05310.0338 ± 0.0588y = −0.00409x + 0.09020.26
GM1_(36:0)ND ± ND0.0285 ± 0.0603ND ± NDND ± ND
GM1_(36:1)ND ± ND0.157 ± 0.3560.125 ± 0.1580.152 ± 0.285y = −0.000926x + 0.1530.02
Hex-Cer_(32:0)0.578 ± 0.440.383 ± 0.5580.199 ± 0.2910.332 ± 0.324y = −0.0341x + 0.6340.57
Hex-Cer_(32:1)ND ± ND0.0486 ± 0.1040.0269 ± 0.0760.0396 ± 0.112y = −0.00167x + 0.05340.17
Hex-Cer_(34:0-OH)0.0882 ± 0.2640.0548 ± 0.1640.0611 ± 0.173ND ± NDy = −0.00502x + 0.09970.58
Hex-Cer_(34:1)0.565 ± 0.7911.27 ± 1.21.74 ± 1.874.68 ± 1.85y = 0.475x − 1.570.84Increasing
Hex-Cer_(34:1-OH)0.295 ± 0.719ND ± ND0.0372 ± 0.1050.208 ± 0.587y = −0.016x + 0.310.25
Hex-Cer_(34:2)0.32 ± 0.4180.318 ± 0.598ND ± ND0.424 ± 1.2y = 0.0138x + 0.2550.88
Hex-Cer_(34:2-OH) 0.614 ± 0.37 0.518 ± 0.375 0.39 ± 0.512 0.306 ± 0.488 y = −0.039x + 0.755 * 0.99 Decreasing
Hex-Cer_(35:0)0.0425 ± 0.127ND ± ND0.663 ± 0.3891.37 ± 1.56y = 0.157x − 0.5790.95
Hex-Cer_(35:1) 0.551 ± 0.625 0.649 ± 0.567 1.03 ± 0.58 1.66 ± 1.57 y = 0.137x − 0.0781 * 0.91 Increasing
Hex-Cer_(36:0-OH) 2.03 ± 1.06 2.58 ± 2.01 3.51 ± 1.07 4.75 ± 2.01 y = 0.337x + 0.642 * 0.97 Increasing
Hex-Cer_(36:1)0.235 ± 0.413ND ± ND0.688 ± 0.6610.264 ± 0.491y = 0.0151x + 0.2740.06
Hex-Cer_(36:2)ND ± ND0.0816 ± 0.2450.289 ± 0.5740.638 ± 0.942y = 0.103x − 0.5910.98
Hex-Cer_(37:0)ND ± ND0.0835 ± 0.1670.0639 ± 0.1810.151 ± 0.295y = 0.0125x − 0.0130.55
Hex-Cer_(37:0-OH)9.56 ± 9.4714.3 ± 11.838 ± 31.680.1 ± 67.3y = 8.72x − 31.20.89Increasing
Hex-Cer_(37:1)0.0494 ± 0.1480.167 ± 0.2520.0497 ± 0.141ND ± NDy = 0.0000556x + 0.08840.00
Hex-Cer_(37:2)2.12 ± 2.983.57 ± 5.060.717 ± 2.030.957 ± 2.02y = −0.235x + 3.640.39
Hex-Cer_(38:0-OH)ND ± ND3.91 ± 5.512.8 ± 4.297.46 ± 8.35y = 0.657x − 1.190.53
Hex-Cer_(38:1)14.8 ± 1613.4 ± 12.322.6 ± 25.132.2 ± 25.2y = 2.27x + 3.350.84
Hex-Cer_(38:2)0.569 ± 0.8992.09 ± 1.231.81 ± 1.580.813 ± 0.906y = 0.0167x + 1.190.01
Hex-Cer_(39:0-OH)5.62 ± 3.392.48 ± 3.24.86 ± 13.819.3 ± 21.8y = 1.61x − 4.240.54
Hex-Cer_(39:2)20.7 ± 4.7121.6 ± 7.524.1 ± 7.7732.5 ± 7.01y = 1.4x + 140.83Increasing
Hex-Cer_(40:0)10.1 ± 12.29.47 ± 1015.5 ± 1519.7 ± 9.5y = 1.29x + 3.820.87
Hex-Cer_(40:0-OH)ND ± ND5 ± 15ND ± NDND ± ND
Hex-Cer_(40:1) 174 ± 204 221 ± 120 275 ± 249 403 ± 206 y = 27.4x + 58.3 * 0.94 Increasing
Hex-Cer_(40:1-OH)7.04 ± 2.486.38 ± 2.947.95 ± 2.575.14 ± 1.51y = −0.153x + 7.80.20
Hex-Cer_(40:2)0.266 ± 0.1780.854 ± 0.8040.806 ± 1.660.672 ± 1.21y = 0.0433x + 0.3180.32
Hex-Cer_(40:2-OH)2.1 ± 1.322.17 ± 0.8912.76 ± 1.91.86 ± 1.91y = −0.00481x + 2.260.00
Hex-Cer_(41:0-OH)23.9 ± 8.733 ± 10.526.8 ± 4.8820.1 ± 7.48y = −0.652x + 30.90.17
Hex-Cer_(41:1)4.01 ± 1.315.78 ± 1.627.62 ± 3.7517.7 ± 5.68y = 1.59x − 3.380.82Increasing
Hex-Cer_(41:2)4.6 ± 1.034.78 ± 1.623.34 ± 1.53.71 ± 1.89y = −0.152x + 5.270.59
Hex-Cer_(42:0)0.394 ± 0.2710.329 ± 0.2890.466 ± 0.2270.705 ± 0.432y = 0.0396x + 0.170.71
Hex-Cer_(42:0-OH)21.8 ± 14.521.3 ± 6.3430.3 ± 20.734.6 ± 14.3y = 1.76x + 13.60.88
Hex-Cer_(42:1) 14.1 ± 4.31 20.5 ± 5.26 22.5 ± 10.5 34.5 ± 12.3 y = 2.34x + 4.99 * 0.92 Increasing
Hex-Cer_(42:2) 7.61 ± 2.29 11.3 ± 3.91 14.3 ± 7.05 23.1 ± 7.39 y = 1.83x + 0.061 * 0.93 Increasing
Hex-Cer_(42:2-OH)4.99 ± 1.665.86 ± 2.355.19 ± 1.867.37 ± 3.43y = 0.24x + 4.020.60
Hex-Cer_(43:0)0.0149 ± 0.02960.0155 ± 0.03080.145 ± 0.1750.129 ± 0.153y = 0.0175x − 0.05760.74
Hex-Cer_(43:0-OH)0.416 ± 0.2550.583 ± 0.360.338 ± 0.180.32 ± 0.277y = −0.0197x + 0.5650.33
Hex-Cer_(43:1)1.69 ± 0.6423.13 ± 1.143.47 ± 1.467.28 ± 2.91y = 0.634x − 0.9550.86Increasing
Hex-Cer_(43:2)0.866 ± 0.2120.858 ± 0.3210.799 ± 0.3141.24 ± 0.718y = 0.0394x + 0.640.46
LPC_(14:0) 1.4 ± 0.645 1.58 ± 0.732 2.09 ± 0.96 2.96 ± 1.34 y = 0.192x + 0.537 * 0.92 Increasing
LPC_(15:0)6.02 ± 1.497.53 ± 2.487.69 ± 2.628.38 ± 2.62y = 0.268x + 5.350.88Increasing
LPC_(16:0) 1430 ± 246 1560 ± 272 1690 ± 300 1900 ± 427 y = 57x + 1210 * 0.98 Increasing
LPC_(16:1) 8.56 ± 4.67 11.3 ± 6.3 19.6 ± 8.38 33.1 ± 10.5 y = 3.03x − 5.07 * 0.92 Increasing
LPC_(17:0)64.5 ± 10.872.2 ± 13.174.9 ± 11.275.6 ± 27.5y = 1.33x + 61.60.84Increasing
LPC_(17:1)0.395 ± 0.3140.576 ± 0.5372.2 ± 1.096.08 ± 1.62y = 0.692x − 2.980.83Increasing
LPC_(18:0) 3720 ± 504 3550 ± 634 3450 ± 619 3300 ± 520 y = −50.4x + 3890 * 0.99 Decreasing
LPC_(18:1)252 ± 47.9247 ± 56.4332 ± 51.2549 ± 121y = 36.1x + 68.50.79
LPC_(18:2) 266 ± 52.6 232 ± 46.8 217 ± 19.7 198 ± 38.2 y = −8.11x + 290 * 0.97 Decreasing
LPC_(18:3) 80 ± 15.2 88.6 ± 22.2 93 ± 19.4 102 ± 22.5 y = 2.61x + 71 * 0.98 Increasing
LPC_(18:4)0.515 ± 0.370.758 ± 0.4811.45 ± 0.7443.08 ± 1.42y = 0.311x − 0.9260.88Increasing
LPC_(19:0)47.8 ± 5.5437.7 ± 12.136.2 ± 8.1940.1 ± 12.9y = −0.911x + 47.40.38
LPC_(20:0) 45.5 ± 12 29 ± 9.84 22.8 ± 4.24 18.5 ± 5.39 y = −3.23x + 53.7 * 0.90 Decreasing
LPC_(20:4)344 ± 121289 ± 32.6288 ± 82.8282 ± 53.7y = −6.93x + 3540.69Decreasing
LPC_(20:5)26.9 ± 9.4921.5 ± 4.3920.2 ± 2.8921 ± 5.62y = −0.704x + 27.80.65
LPC_(21:0)1.11 ± 0.2270.89 ± 0.3050.75 ± 0.2570.896 ± 0.324y = −0.029x + 1.130.46
LPC_(22:4)5.12 ± 2.833.37 ± 0.7943.21 ± 0.9093.52 ± 1y = −0.184x + 5.210.52
LPC_(22:5)12.3 ± 9.446.01 ± 2.435.97 ± 2.519.46 ± 4.97y = −0.317x + 10.90.13
LPC_(22:6)21.1 ± 1314.4 ± 3.3315.4 ± 4.7426.5 ± 5.75y = 0.637x + 14.50.16
LPE_(16:0) 9.94 ± 2.69 11.4 ± 3.82 16.7 ± 4.93 25.8 ± 11.7 y = 1.96x + 0.977 * 0.91 Increasing
LPE_(16:1)ND ± ND0.0351 ± 0.07090.0116 ± 0.03290.177 ± 0.163y = 0.0263x − 0.1620.63
LPE_(17:0) 0.637 ± 0.392 0.724 ± 0.401 1.1 ± 0.151 1.61 ± 0.982 y = 0.122x + 0.0842 * 0.92 Increasing
LPE_(18:0)50.7 ± 12.950.3 ± 14.657.1 ± 12.667.7 ± 29.3y = 2.14x + 40.10.84
LPE_(18:1)5.94 ± 1.164.7 ± 1.216.6 ± 1.3611 ± 3.41y = 0.633x + 2.220.65
LPE_(18:2)5.04 ± 3.82.76 ± 1.332.93 ± 1.152.42 ± 1.28y = −0.285x + 5.470.70
LPE_(18:3) 1.85 ± 0.528 2.14 ± 0.76 2.96 ± 0.944 4.22 ± 1.93 y = 0.294x + 0.546 * 0.93 Increasing
LPE_(20:0) 0.444 ± 0.114 0.358 ± 0.169 0.31 ± 0.121 0.247 ± 0.17 y = −0.0237x + 0.521 * 0.99 Decreasing
LPE_(20:3) 0.472 ± 0.645 0.556 ± 0.49 0.945 ± 0.831 1.49 ± 1.22 y = 0.128x − 0.11 * 0.92 Increasing
LPE_(20:4)22.9 ± 12.317.9 ± 4.5320.8 ± 7.6628.6 ± 11.8y = 0.741x + 16.90.33
LPE_(20:5)1.53 ± 1.120.932 ± 0.3880.827 ± 0.2520.645 ± 0.248y = −0.102x + 1.770.86Decreasing
LPE_(22:4)0.264 ± 0.791ND ± ND0.0209 ± 0.03890.35 ± 0.382y = 0.00267x + 0.190.00
LPI_(16:0)64.1 ± 21.482.6 ± 36.1113 ± 39.7103 ± 45y = 5.45x + 490.76
LPI_(17:0)5.04 ± 3.176.56 ± 3.137.63 ± 3.85.1 ± 4.85y = 0.0463x + 5.730.02
LPI_(18:0)1210 ± 4041510 ± 6471510 ± 3761200 ± 547y = −1.11x + 13700.00
LPI_(18:1) 46.2 ± 22.3 47.6 ± 17.7 57.4 ± 21.6 59.5 ± 26.8 y = 1.84x + 38.6 * 0.90 Increasing
LPI_(18:2)18.9 ± 10.417.8 ± 816.9 ± 5.867.43 ± 4.45y = −1.31x + 25.30.74Decreasing
LPI_(20:0)0.0835 ± 0.1ND ± ND0.18 ± 0.2640.0895 ± 0.127y = 0.00319x + 0.09180.06
LPI_(20:2) 1.7 ± 1.09 1.18 ± 1.36 1.09 ± 0.93 0.661 ± 1.15 y = −0.119x + 2.07 * 0.94 Decreasing
LPI_(20:3) 25.8 ± 14.7 47.1 ± 27.2 85.6 ± 35.3 125 ± 49.4 y = 12.4x − 24.4 * 0.98 Increasing
LPI_(20:4)288 ± 102453 ± 238447 ± 108360 ± 145y = 7.78x + 3280.12
LPI_(22:4)4.72 ± 2.123.96 ± 2.884.26 ± 2.13.26 ± 1.91y = −0.151x + 5.210.74
LPI_(22:5)1.15 ± 1.671.51 ± 1.760.418 ± 0.7011.98 ± 1.41y = 0.0518x + 0.8680.08
LPI_(22:6)2.06 ± 1.552.04 ± 1.580.605 ± 0.9682.65 ± 2.37y = 0.0124x + 1.740.00
Lyso_CL_(52:01)0.698 ± 1.021.75 ± 1.421.51 ± 0.7551.99 ± 1.82y = 0.135x + 0.4570.70
Lyso_CL_(52:02)11.4 ± 10.413.7 ± 7.6710.7 ± 4.912.5 ± 11.6y = 0.0111x + 120.00
Lyso_CL_(52:03) 50.5 ± 42.8 32.9 ± 12.7 18.7 ± 8.32 17.2 ± 14.1 y = −4.23x + 62.2 * 0.90 Decreasing
Lyso_CL_(52:04)30.3 ± 36.619.7 ± 9.879.23 ± 4.2110.4 ± 9.01y = −2.6x + 37.30.86
Lyso_CL_(52:05)ND ± NDND ± NDND ± ND0.785 ± 1.84
Lyso_CL_(53:04)ND ± ND0.154 ± 0.2610.221 ± 0.4041.55 ± 1.72y = 0.259x − 1.690.79
Lyso_CL_(54:02)ND ± ND0.0851 ± 0.1780.0412 ± 0.1170.655 ± 1.15y = 0.106x − 0.6890.69
Lyso_CL_(54:03)24.8 ± 26.613.2 ± 7.19.89 ± 3.8819.5 ± 18.6y = −0.711x + 22.30.14
Lyso_CL_(54:04)172 ± 16694.9 ± 32.467.3 ± 25.287 ± 72.4y = −10.5x + 1850.63
Lyso_CL_(54:05)405 ± 411234 ± 94144 ± 60.4133 ± 104y = −33.6x + 4860.87Decreasing
Lyso_CL_(54:06)548 ± 555247 ± 117122 ± 47.865.7 ± 51.8y = −58.2x + 6910.89Decreasing
Lyso_CL_(56:05)42.9 ± 55.313.1 ± 3.274.18 ± 2.4113.5 ± 16.1y = −3.6x + 45.90.55
Lyso_CL_(56:06)135 ± 15342.7 ± 13.420.9 ± 8.3340.2 ± 42.2y = −11.3x + 1460.60
PA_(30:0)1.19 ± 2.412.63 ± 2.776.15 ± 4.8330 ± 23.7y = 3.33x − 15.50.74Increasing
PA_(30:1)17.2 ± 17.817.1 ± 11.820.7 ± 9.9873.9 ± 41.3y = 6.43x − 170.65
PA_(32:1)43.2 ± 46.556.3 ± 17.784.6 ± 30.3291 ± 143y = 28.6x − 99.90.74Increasing
PA_(32:2)223 ± 216180 ± 96154 ± 86.4166 ± 70.4y = −7.3x + 2370.71
PA_(34:1)387 ± 401402 ± 135538 ± 1761010 ± 307y = 74.3x + 16.20.79Increasing
PA_(34:2) 2330 ± 2170 1990 ± 756 1600 ± 787 1230 ± 358 y = −137x + 2830 * 1.00 Decreasing
PA_(36:1)1440 ± 9241640 ± 4351410 ± 8771240 ± 323y = −30.7x + 16700.43
PA_(36:2) 3310 ± 1750 2480 ± 918 2250 ± 1360 1910 ± 1020 y = −164x + 3740 * 0.92 Decreasing
PA_(36:4)10,300 ± 99706760 ± 28407130 ± 37909580 ± 4540y = −66.3x + 89500.02
PA_(38:3)1390 ± 9101150 ± 5441590 ± 6832590 ± 1230y = 150x + 5350.68
PA_(38:4)42,400 ± 40,10027,100 ± 11,70025,400 ± 17,00023,000 ± 7630y = −2220x + 46,4000.78Decreasing
PA_(38:5)3280 ± 28002230 ± 9112430 ± 11803310 ± 1300y = 10.7x + 27300.00
PA_(40:5)1730 ± 1530838 ± 336871 ± 4491110 ± 412y = −67.7x + 16500.33
PC_(30:0) 6.27 ± 6.94 21.5 ± 23.9 39.3 ± 18.4 81.4 ± 23.1 y = 9.01x − 31.8 * 0.94 Increasing
PC_(30:1)8.63 ± 6.2412.9 ± 8.5240.6 ± 32.6188 ± 120y = 21x − 97.80.74Increasing
PC_(31:0)54.7 ± 17.478.7 ± 33.585.4 ± 22.6179 ± 44.5y = 14.1x − 8.10.80Increasing
PC_(32:0)1750 ± 2511930 ± 4931650 ± 2371950 ± 234y = 11.9x + 17300.08
PC_(32:1)222 ± 110352 ± 1011240 ± 8354860 ± 1550y = 548x − 25300.77Increasing
PC_(32:2)565 ± 249496 ± 222646 ± 2231350 ± 659y = 92.8x + 54.50.67
PC_(33:0)28.2 ± 8.5539.9 ± 1349.6 ± 7.5102 ± 25.7y = 8.56x − 10.60.84Increasing
PC_(33:1)148 ± 45.4267 ± 71.4540 ± 1361700 ± 388y = 183x − 7330.80Increasing
PC_(33:2)470 ± 56.2515 ± 187574 ± 241566 ± 180y = 12.9x + 4330.85
PC_(34:0)789 ± 267732 ± 165615 ± 45.6644 ± 83.3y = −20.4x + 8510.79
PC_(34:1)4160 ± 7635580 ± 9318080 ± 82915,100 ± 1050y = 1310x − 17800.88Increasing
PC_(34:2)11,900 ± 205014,700 ± 188015,200 ± 193020,400 ± 2030y = 963x + 81800.90Increasing
PC_(34:3)3270 ± 10903620 ± 8345400 ± 9989050 ± 1860y = 708x − 82.30.87Increasing
PC_(35:0)28.3 ± 9.2732.3 ± 9.1138.3 ± 6.871.2 ± 15.2y = 4.99x + 4.360.79Increasing
PC_(35:1)108 ± 32166 ± 36.7297 ± 52.6891 ± 153y = 91.9x − 3370.79Increasing
PC_(35:2)1240 ± 2381530 ± 3051530 ± 4331640 ± 369y = 44.4x + 11500.82
PC_(36:0)76.2 ± 27.666.4 ± 16.655.2 ± 22.983.4 ± 16.5y = 0.385x + 67.40.01
PC_(36:1)3060 ± 7533610 ± 7565450 ± 94411,600 ± 974y = 1020x − 18500.82Increasing
PC_(36:2)6650 ± 11807290 ± 13207890 ± 149010,700 ± 954y = 472x + 45200.85Increasing
PC_(36:3)8480 ± 9129060 ± 157011,800 ± 192023,900 ± 2150y = 1810x − 5730.77Increasing
PC_(36:4)18,900 ± 312020,200 ± 270019,500 ± 119027,500 ± 1900y = 930x + 14,4000.65
PC_(37:0)0.557 ± 0.40.542 ± 0.2320.338 ± 0.2310.689 ± 0.551y = 0.00711x + 0.4770.03
PC_(37:1)40.9 ± 20.838 ± 19.475.1 ± 38.1283 ± 96.2y = 28.3x − 1070.71
PC_(37:2)301 ± 88.2217 ± 62.9210 ± 61.6301 ± 56.6y = −0.259x + 2590.00
PC_(37:3) 83.4 ± 17.3 86.2 ± 25.1 131 ± 33.9 160 ± 31.9 y = 10.2x + 37.3 * 0.92 Increasing
PC_(37:4)2810 ± 6483180 ± 7382520 ± 6742430 ± 461y = −66.7x + 32500.47
PC_(37:5)157 ± 59.9171 ± 36.4270 ± 103445 ± 77.3y = 35.7x − 12.10.88Increasing
PC_(37:6)85 ± 34.376 ± 37.555.8 ± 29.9101 ± 29.7y = 1.03x + 71.60.04
PC_(38:0)1.83 ± 0.3231.77 ± 0.4321.79 ± 0.7732.67 ± 0.91y = 0.0941x + 1.30.56
PC_(38:1)39.4 ± 20.914.1 ± 12.828.9 ± 21.3103 ± 42.3y = 7.61x − 11.90.46
PC_(38:2)649 ± 137521 ± 186493 ± 137871 ± 171y = 23.6x + 4530.23
PC_(38:3)3030 ± 3463260 ± 7085020 ± 105012,200 ± 1770y = 1080x − 24200.77Increasing
PC_(38:4)10,300 ± 201011,700 ± 224010,200 ± 109012,100 ± 2290y = 144x + 99700.27
PC_(38:5)6010 ± 20505500 ± 19005290 ± 9168730 ± 1930y = 294x + 41300.41
PC_(38:6)16,000 ± 353014,000 ± 155012,900 ± 169018,900 ± 2600y = 281x + 13,3000.14
PC_(40:2)19.1 ± 8.4814.8 ± 4.3713.2 ± 3.2120.1 ± 5.31y = 0.0519x + 16.40.00
PC_(40:3)52.8 ± 1544 ± 15.152.7 ± 13.6124 ± 22.6y = 8.23x + 5.390.59
PC_(40:4) 1200 ± 402 884 ± 230 726 ± 182 665 ± 175 y = −65.3x + 1370 * 0.90 Decreasing
PC_(40:5)947 ± 577704 ± 574514 ± 208980 ± 459y = −3.37x + 8120.00
PC_(40:6)3800 ± 9363630 ± 9133090 ± 7204370 ± 960y = 43.3x + 33900.08
PC_C18(plas)-18:1ND ± NDND ± NDND ± ND0.766 ± 1.43
PE_(30:0)4.78 ± 10.72.19 ± 4.47ND ± ND1.82 ± 5.14y = −0.323x + 5.260.68
PE_(32:1)12.4 ± 20.926 ± 38.5468 ± 5531920 ± 896y = 228x − 11400.78Increasing
PE_(34:0)80.3 ± 34.4106 ± 2454.8 ± 20.830.5 ± 35.6y = −7.43x + 1250.63
PE_(34:1)4110 ± 22204930 ± 18009030 ± 194018,100 ± 6000y = 1710x − 40100.86Increasing
PE_(34:2) 71,600 ± 27,000 69,300 ± 42,400 48,600 ± 14,200 29,500 ± 12,000 y = −5440x + 96,400 * 0.92 Decreasing
PE_(35:1) 4.9 ± 2 10.6 ± 3.84 23.9 ± 7.89 42.4 ± 13 y = 4.66x − 15.2 * 0.95 Increasing
PE_(36:0)24.4 ± 11.335 ± 1522.8 ± 6.6817 ± 12.8y = −1.27x + 34.50.35
PE_(36:1)6560 ± 40605730 ± 26006590 ± 173011,300 ± 4870y = 559x + 32700.59
PE_(36:2) 46,300 ± 18,900 36,900 ± 20,900 24,400 ± 6230 19,300 ± 7930 y = −3460x + 58,200 * 0.98 Decreasing
PE_(36:3) 39,000 ± 15,000 28,800 ± 17,100 20,000 ± 4520 14,300 ± 5490 y = −3070x + 49,000 * 0.99 Decreasing
PE_(36:4)110,000 ± 44,700107,000 ± 49,20096,600 ± 12,500126,000 ± 34,500y = 1390x + 99,2000.16
PE_(38:1)219 ± 130144 ± 84.5115 ± 22121 ± 46.7y = −12x + 2410.76
PE_(38:2)1530 ± 645822 ± 467539 ± 98.4535 ± 140y = −121x + 17800.81Decreasing
PE_(38:3)13400 ± 493013,000 ± 770014,400 ± 271017,700 ± 3860y = 530x + 10,6000.75
PE_(38:4)165,000 ± 74,800148,000 ± 59,300113,000 ± 20,200118,000 ± 26,000y = −6520x + 186,0000.84
PE_(38:5)72,900 ± 38,40052,700 ± 23,20039,700 ± 715044,700 ± 11,600y = −3610x + 80,2000.74
PE_(38:6)25,000 ± 12,00018,200 ± 827012,300 ± 289019,100 ± 5400y = −874x + 25,3000.34
PG_(32:0)1.64 ± 0.7481.59 ± 0.8345.29 ± 4.0511 ± 3.46y = 1.18x − 4.120.86
PG_(33:0)ND ± NDND ± NDND ± ND0.0213 ± 0.0434
PG_(34:1)ND ± NDND ± ND2.24 ± 3.1965.1 ± 51.8y = 23.3x − 2071.00
PG_(35:1) 0.256 ± 0.325 0.467 ± 0.67 0.816 ± 0.888 1.62 ± 0.913 y = 0.164x − 0.469 * 0.91 Increasing
PG_(36:0)11.8 ± 3.7525.6 ± 1813.4 ± 4.497.6 ± 5.1y = −0.919x + 21.60.17
PG_(36:1)0.0408 ± 0.1221.84 ± 2.720.525 ± 0.620.294 ± 0.831y = −0.0206x + 0.8320.01
PG_(36:2)125 ± 25.3169 ± 81.3106 ± 43.153.5 ± 21y = −10.3x + 1920.56
PG_(36:3)48.8 ± 14.262.3 ± 3032.3 ± 9.5328.1 ± 20.5y = −3.41x + 690.57
PG_(36:4)25.6 ± 13.645.9 ± 26.933.6 ± 15.729.1 ± 15.4y = −0.0667x + 34.10.00
PG_(38:3)1.72 ± 1.421.04 ± 0.7533.19 ± 3.437.34 ± 3.64y = 0.704x − 2.060.75
PG_(38:4)11.7 ± 5.7619.5 ± 9.913.3 ± 5.2211.9 ± 5.31y = −0.207x + 15.70.04
PG_(38:5)6.31 ± 2.829.55 ± 5.476.6 ± 2.347.16 ± 4.03y = −0.0148x + 7.520.00
PG_(38:6)0.0292 ± 0.08760.0656 ± 0.07540.0529 ± 0.0670.0457 ± 0.0527y = 0.00136x + 0.03790.10
PG_(40:6)0.306 ± 0.3780.211 ± 0.4340.028 ± 0.07920.773 ± 0.913y = 0.0451x − 0.01560.25
PG_(42:07)0.469 ± 0.4110.424 ± 0.7140.269 ± 0.3320.305 ± 0.316y = −0.024x + 0.550.77
PG_(42:08)0.0147 ± 0.01920.0893 ± 0.110.112 ± 0.116ND ± NDy = 0.018x − 0.04150.91Increasing
PG_(42:10)0.0638 ± 0.1910.314 ± 0.943ND ± ND0.0417 ± 0.118y = -0.00954x + 0.2090.07
PI_(34:0)455 ± 385482 ± 396354 ± 237318 ± 196y = −20x + 5550.78
PI_(34:1)5070 ± 14205070 ± 9097620 ± 162010,100 ± 2670y = 653x + 19700.89
PI_(34:2)6510 ± 38509740 ± 41409450 ± 38803260 ± 1640y = −372x + 10,1000.18
PI_(35:0)0.0814 ± 0.2440.0917 ± 0.275ND ± NDND ± NDy = 0.00381x + 0.06771.00
PI_(35:2)134 ± 112319 ± 164261 ± 13782.5 ± 68.9y = −7.87x + 2590.06
PI_(36:1) 186 ± 165 450 ± 292 659 ± 339 814 ± 589 y = 77.5x − 65.8 * 0.99 Increasing
PI_(36:2)3680 ± 26705400 ± 27204920 ± 23002020 ± 1140y = −202x + 55500.22
PI_(36:4)16,000 ± 672025,800 ± 10,60027,900 ± 874021,000 ± 9500y = 633x + 17,8000.17
PI_(38:3)6340 ± 402010,500 ± 671014,200 ± 80606420 ± 3950y = 146x + 82500.02
PI_(38:4)86,600 ± 41,000124,000 ± 50,900119,000 ± 34,00079,600 ± 40,400y = −963x + 110,0000.02
PI_(38:5)11,100 ± 540015,000 ± 575016,600 ± 489012,400 ± 5840y = 204x + 12,2000.08
PI_(40:3) 120 ± 56.6 94 ± 51.8 49.8 ± 19 25.2 ± 8.08 y = −12.2x + 165 * 0.99 Decreasing
PI_(40:4)1040 ± 6151830 ± 10501380 ± 608885 ± 607y = −33.9x + 15400.08
PI_(40:6)4080 ± 10205270 ± 13504820 ± 9016870 ± 1270y = 293x + 30200.75
PI_(40:8)42.9 ± 2548.9 ± 23.447.4 ± 22.150.8 ± 21y = 0.822x + 41.20.72
PS_(32:0)0.673 ± 0.5870.661 ± 0.9180.321 ± 0.1350.802 ± 0.336y = 0.00174x + 0.6010.00
PS_(32:1)0.00219 ± 0.006580.0339 ± 0.03290.00448 ± 0.01270.00374 ± 0.0106y = −0.000917x + 0.01810.04
PS_(33:1)1.25 ± 0.5041.76 ± 0.5411.8 ± 0.5531.19 ± 1.06y = −0.00519x + 1.540.00
PS_(34:0)0.0337 ± 0.1010.291 ± 0.4520.16 ± 0.2110.0675 ± 0.096y = −0.0011x + 0.1460.00
PS_(34:1)ND ± ND0.0315 ± 0.0945ND ± ND0.73 ± 0.911y = 0.129x − 0.7831.00
PS_(34:2)10.3 ± 4.0513.8 ± 4.6915.3 ± 4.3411.7 ± 5.1y = 0.211x + 11.20.11
PS_(34:3)0.051 ± 0.08210.0582 ± 0.1150.202 ± 0.3140.911 ± 0.888y = 0.101x − 0.4660.74Increasing
PS_(35:2)0.215 ± 0.5140.379 ± 0.9460.0732 ± 0.2070.101 ± 0.286y = −0.024x + 0.3760.36
PS_(36:0)0.242 ± 0.4790.34 ± 0.5270.261 ± 0.4890.485 ± 0.672y = 0.0241x + 0.1480.58
PS_(36:1)63.9 ± 28.7135 ± 76.6101 ± 23.575.4 ± 43y = 0.0185x + 93.70.00
PS_(36:2)115 ± 47136 ± 51.5123 ± 33.283 ± 23.2y = −4.04x + 1450.39
PS_(38:2)0.434 ± 0.5781.66 ± 1.780.712 ± 0.420.536 ± 0.84y = −0.0238x + 1.020.02
PS_(38:5)ND ± ND0.0745 ± 0.224ND ± NDND ± ND
PS_(38:6)113 ± 23.8126 ± 29.7140 ± 34.3201 ± 55.3y = 10.3x + 66.20.85Increasing
PS_(40:0)0.352 ± 0.4061.18 ± 0.5990.755 ± 0.5661.46 ± 0.838y = 0.107x + 0.1150.59
PS_(40:2)0.485 ± 1.311.23 ± 2.17ND ± NDND ± NDy = 0.276x − 0.5081.00
PS_(40:3)215 ± 36.3243 ± 49.1206 ± 51.9147 ± 28.2y = −8.93x + 2710.59
PS_(42:6)185 ± 75.9262 ± 104237 ± 95.887.8 ± 37.6y = −11.7x + 2830.28
S_(32:0)0.134 ± 0.03790.128 ± 0.05380.112 ± 0.01570.0075 ± 0.014y = −0.0146x + 0.2070.74Decreasing
S_(32:1)ND ± NDND ± NDND ± ND0.000566 ± 0.0016
S_(34:0)1.04 ± 0.1052.09 ± 1.771.54 ± 0.2591.31 ± 0.586y = 0.00963x + 1.420.01
S_(34:1-OH)1.47 ± 0.481.72 ± 0.7951.08 ± 0.3881.35 ± 0.9y = −0.037x + 1.690.24
S_(34:2)0.592 ± 0.1470.769 ± 0.360.402 ± 0.1870.327 ± 0.128y = −0.043x + 0.8520.57
S_(35:0)0.0316 ± 0.06170.022 ± 0.03690.0626 ± 0.1230.0338 ± 0.0371y = 0.00175x + 0.02410.12
S_(35:1)0.0235 ± 0.0410.021 ± 0.03440.0404 ± 0.09220.16 ± 0.307y = 0.0159x − 0.06030.70
S_(35:1-OH)0.209 ± 0.2810.127 ± 0.381ND ± NDND ± NDy = −0.0304x + 0.3181.00
S_(35:2)ND ± NDND ± ND0.00482 ± 0.008970.00385 ± 0.00881y = −0.000359x + 0.008051.00
S_(36:1)0.999 ± 0.4371 ± 0.6610.824 ± 0.3750.561 ± 0.391y = −0.0552x + 1.270.86
S_(37:2)0.159 ± 0.0920.296 ± 0.220.206 ± 0.1250.08 ± 0.0753y = −0.0121x + 0.2780.22
S_(38:0)1.88 ± 0.6313.39 ± 2.131.89 ± 0.6841.03 ± 0.594y = −0.15x + 3.20.28
S_(38:1-OH)0.153 ± 0.2420.197 ± 0.3080.116 ± 0.2530.0765 ± 0.109y = −0.0115x + 0.2240.61
S_(39:1)0.111 ± 0.09480.41 ± 0.6320.194 ± 0.2490.0621 ± 0.12y = −0.0134x + 0.2970.09
S_(40:0)7.77 ± 1.4317.9 ± 12.710.5 ± 4.517.67 ± 4.6y = −0.285x + 13.10.04
S_(40:1-OH)1.48 ± 0.8151.78 ± 1.371.57 ± 0.9091.46 ± 1.39y = −0.01x + 1.650.06
S_(40:2)1.04 ± 0.6371.44 ± 0.8411.03 ± 0.4250.566 ± 0.349y = −0.0679x + 1.540.44
S_(41:0)0.352 ± 0.1951.1 ± 0.9430.253 ± 0.1620.0222 ± 0.0413y = −0.068x + 0.9520.26
S_(41:2)ND ± ND0.0108 ± 0.03240.021 ± 0.03180.0543 ± 0.0655y = 0.00806x − 0.04380.91
S_(42:0)0.322 ± 0.2250.59 ± 0.8760.491 ± 0.2230.294 ± 0.162y = −0.00678x + 0.4760.03
S_(42:2)0.395 ± 0.3851.1 ± 1.260.958 ± 0.8370.983 ± 0.763y = 0.0601x + 0.3990.44
S_(42:2-OH)2.43 ± 0.8431.55 ± 0.5880.786 ± 0.4060.789 ± 0.434y = −0.211x + 30.88
S_(46:2-OH)0.0599 ± 0.03370.0149 ± 0.02690.0228 ± 0.0180.0258 ± 0.031y = −0.0035x + 0.05760.37
S_(48:2-OH)0.00958 ± 0.0163ND ± ND0.00395 ± 0.007310.00115 ± 0.00326y = −0.00104x + 0.01331.00
SM_(30:1)1.61 ± 0.2621.59 ± 0.6111.89 ± 0.6791.84 ± 0.667y = 0.0367x + 1.450.68
SM_(32:0) 4.99 ± 0.941 4.66 ± 2.13 3.81 ± 1.08 2.85 ± 1.21 y = −0.269x + 6.14 * 0.96 Decreasing
SM_(32:1) 428 ± 88.3 368 ± 107 334 ± 87.3 256 ± 63.6 y = −20.4x + 502 * 0.98 Decreasing
SM_(33:1) 273 ± 37.3 238 ± 62.2 168 ± 32.2 135 ± 44.4 y = −17.9x + 341 * 0.98 Decreasing
SM_(34:0)21.8 ± 5.9826 ± 6.4922.2 ± 6.6518 ± 4.85y = −0.563x + 26.30.36
SM_(34:0-OH) 7.39 ± 2.3 5.26 ± 2.46 3.5 ± 1.7 1.4 ± 1.69 y = −0.731x + 9.98 * 1.00 Decreasing
SM_(34:1)3400 ± 4953830 ± 7963240 ± 4272620 ± 346y = −109x + 41000.57
SM_(34:1-OH)4.36 ± 1.6310.1 ± 85.89 ± 3.222.74 ± 2.48y = −0.336x + 8.340.14
SM_(34:2)397 ± 102401 ± 106320 ± 50.4282 ± 94.6y = −15.8x + 4710.88
SM_(34:2-OH) 4.44 ± 1.37 4.15 ± 1.73 3.2 ± 0.88 2.68 ± 0.928 y = −0.231x + 5.38 * 0.96 Decreasing
SM_(35:0)0.957 ± 1.350.969 ± 0.8480.457 ± 0.2670.389 ± 0.404y = −0.0821x + 1.320.84
SM_(35:1)36.3 ± 3.7448.6 ± 6.5340.9 ± 7.541.1 ± 8.38y = 0.248x + 39.80.03
SM_(35:2)0.632 ± 0.4560.335 ± 0.3140.144 ± 0.1490.137 ± 0.18y = −0.0621x + 0.7870.87Decreasing
SM_(36:1)449 ± 43.4529 ± 103446 ± 58.3298 ± 50.5y = −19.9x + 5820.52
SM_(36:2)32 ± 6.2438.6 ± 9.3530.9 ± 4.5223.1 ± 5.49y = −1.27x + 40.90.49
SM_(36:3) 2.19 ± 0.784 1.71 ± 0.891 0.76 ± 0.384 0.406 ± 0.326 y = −0.233x + 3.05 * 0.97 Decreasing
SM_(37:2)0.0328 ± 0.09840.024 ± 0.0721ND ± ND0.0197 ± 0.0556y = −0.0015x + 0.03630.86
SM_(38:0)7.73 ± 1.457.83 ± 3.246.35 ± 1.814.64 ± 1.6y = −0.398x + 9.680.86
SM_(38:1) 342 ± 56.4 293 ± 59.3 200 ± 27.7 106 ± 19.4 y = −29.7x + 462 * 0.98 Decreasing
SM_(39:0)8.55 ± 3.438.71 ± 6.7812.5 ± 7.79ND ± NDy = 0.731x + 5.310.78Increasing
SM_(39:1) 178 ± 28.6 142 ± 35.5 109 ± 28.1 85.4 ± 10.7 y = −11.5x + 217 * 0.99 Decreasing
SM_(40:0) 17.3 ± 5.88 14.2 ± 4.27 10.8 ± 2.35 4.03 ± 1.2 y = −1.6x + 23.8 * 0.96 Decreasing
SM_(40:0-OH) 5.96 ± 1.62 4.29 ± 1.17 3.53 ± 1.12 0.919 ± 0.868 y = −0.588x + 8.17 * 0.95 Decreasing
SM_(40:1) 989 ± 137 867 ± 181 704 ± 125 520 ± 71.7 y = −58.1x + 1210 * 0.99 Decreasing
SM_(40:2) 138 ± 21.3 123 ± 21.6 91.7 ± 16.9 55.3 ± 11.1 y = −10.3x + 181 * 0.97 Decreasing
SM_(41:0)8.36 ± 2.458.68 ± 2.137.03 ± 1.565.33 ± 1.63y = −0.398x + 10.40.83
SM_(41:1) 893 ± 123 839 ± 144 772 ± 135 695 ± 133 y = −24.5x + 987 * 0.99 Decreasing
SM_(42:0)8.67 ± 2.4710.5 ± 3.947.13 ± 2.873.17 ± 1.49y = −0.736x + 130.68
SM_(42:0-OH) 12.7 ± 2.47 11.1 ± 1.98 9.01 ± 2.88 4.92 ± 1.53 y = −0.942x + 16.6 * 0.95 Decreasing
SM_(42:1) 1610 ± 185 1540 ± 227 1280 ± 206 1020 ± 194 y = −75.2x + 1940 * 0.95 Decreasing
SM_(42:2)1160 ± 1801180 ± 1851010 ± 197880 ± 109y = −37.4x + 13400.86
SM_(43:0)0.202 ± 0.1190.527 ± 0.2750.368 ± 0.1990.115 ± 0.152y = −0.0156x + 0.4220.09
SM_(43:1)158 ± 43.1200 ± 35.8163 ± 44.2153 ± 57y = −1.93x + 1830.10
SM_(44:1)13.5 ± 4.2417.9 ± 3.614.1 ± 4.999.32 ± 3.95y = −0.605x + 18.30.36
SM_(44:2)27 ± 6.1729.6 ± 5.3127 ± 7.8423.1 ± 5.83y = −0.53x + 30.70.47
TG_(18:0)11 ± 8.9111.3 ± 4.516.54 ± 4.042.47 ± 2.6y = −1.12x + 16.40.88
TG_(24:0)920 ± 250039.9 ± 59.684.9 ± 195177 ± 372y = −80.9x + 9240.46
TG_(36:0)170 ± 21452.4 ± 36.993.4 ± 83.8441 ± 288y = 31.6x − 52.80.40
TG_(44:1)970 ± 941325 ± 1751550 ± 21302250 ± 1250y = 188x − 1610.63
TG_(45:1)14.3 ± 197.72 ± 5.8732.3 ± 32.383.7 ± 49.3y = 8.62x − 31.40.76
TG_(45:2)92.6 ± 86.231.6 ± 14.864.1 ± 58.784.2 ± 53.8y = 0.27x + 66.10.00
TG_(46:1)85.4 ± 10422.5 ± 16.187.6 ± 112269 ± 189y = 22.8x − 58.40.56
TG_(46:2)1060 ± 1040293 ± 167412 ± 311787 ± 609y = -25.9x + 8360.07
TG_(46:4)3530 ± 3550700 ± 350464 ± 357316 ± 241y = −366x + 40500.70Decreasing
TG_(47:0)7.11 ± 72.59 ± 2.232.86 ± 4.16.91 ± 2.88y = −0.0122x + 4.960.00
TG_(47:1)1.39 ± 3.190.253 ± 0.766.65 ± 10.219.6 ± 9.01y = 2.26x − 10.30.79
TG_(47:2)11.5 ± 11.33.39 ± 2.8710.9 ± 6.9422.3 ± 17.7y = 1.48x + 0.7150.44
TG_(48:0)133 ± 69.663 ± 10.975.7 ± 98.492.4 ± 43.9y = −4.04x + 1220.21
TG_(48:1)142 ± 10083 ± 29.2279 ± 343435 ± 172y = 39.8x − 69.80.78
TG_(48:2)241 ± 196115 ± 38.3319 ± 401440 ± 165y = 29.7x + 51.80.57
TG_(48:3)250 ± 18583.7 ± 27112 ± 80.1102 ± 49.9y = −15.4x + 2550.49
TG_(49:0)18 ± 9.1610.7 ± 2.1211 ± 5.6910.2 ± 3.69y = −0.856x + 190.65
TG_(49:1)35.7 ± 18.628.3 ± 9.6767.9 ± 55.596.3 ± 30.3y = 8.2x − 5.680.83
TG_(49:2)70.2 ± 29.850.1 ± 12.177.6 ± 55.486.3 ± 30.3y = 2.81x + 49.60.40
TG_(49:3)27.3 ± 12.918.2 ± 5.0326.8 ± 15.419.3 ± 7.36y = −0.57x + 27.30.17
TG_(50:0)178 ± 68.6118 ± 20.3125 ± 57.6102 ± 37.6y = −8.19x + 1930.75
TG_(50:1)1440 ± 5481030 ± 3391870 ± 13701870 ± 858y = 78.9x + 9490.47
TG_(50:2)2750 ± 12101830 ± 4582920 ± 22002920 ± 1010y = 59.3x + 21500.16
TG_(50:3)1500 ± 8581050 ± 2831760 ± 13701040 ± 452y = −24.8x + 15300.06
TG_(51:1)79 ± 30.978.4 ± 31.8138 ± 102124 ± 39.6y = 7.21x + 49.70.67
TG_(51:2)296 ± 163274 ± 82.5532 ± 293509 ± 148y = 33.2x + 1490.72
TG_(51:3) 648 ± 459 467 ± 133 437 ± 175 186 ± 86.3 y = −52.4x + 836 * 0.92 Decreasing
TG_(51:4) 662 ± 568 330 ± 121 150 ± 55.5 37.2 ± 17.5 y = −76.1x + 877 * 0.94 Decreasing
TG_(52:0) 128 ± 70.4 80.4 ± 17.6 69.5 ± 28.8 47.4 ± 24.1 y = −9.36x + 153 * 0.92 Decreasing
TG_(52:1)849 ± 304716 ± 3111130 ± 904823 ± 275y = 12.4x + 7840.06
TG_(52:2)12,300 ± 64609670 ± 323012,700 ± 60008610 ± 3300y = −298x + 13,1000.27
TG_(52:3) 36,800 ± 25,800 22,700 ± 5870 15,800 ± 5770 5160 ± 2670 y = −3770x + 49,000 * 0.98 Decreasing
TG_(52:4) 45,200 ± 36,700 21,100 ± 7240 9760 ± 3330 2220 ± 1880 y = −5200x + 59,300 * 0.93 Decreasing
TG_(53:1)28.5 ± 8.4223.8 ± 10.336.4 ± 29.325.5 ± 8.57y = 0.133x + 27.50.01
TG_(53:2)253 ± 129240 ± 109353 ± 259214 ± 67.8y = −0.148x + 2660.00
TG_(53:3) 801 ± 527 518 ± 145 470 ± 175 183 ± 73.3 y = −70.4x + 1030 * 0.94 Decreasing
TG_(53:4) 877 ± 722 489 ± 180 277 ± 100 75.2 ± 38.5 y = −96.9x + 1170 * 0.97 Decreasing
TG_(54:0)20.1 ± 12.811.5 ± 2.279.51 ± 3.737.25 ± 5.07y = −1.5x + 23.60.87Decreasing
TG_(54:1)117 ± 54.879 ± 24.196.6 ± 86.657.2 ± 25.8y = −5.99x + 1330.67
TG_(54:2)866 ± 326637 ± 373805 ± 731408 ± 146y = −44.7x + 10200.58
TG_(54:3) 5400 ± 3270 2880 ± 1140 2350 ± 1060 1000 ± 436 y = −509x + 6800 * 0.93 Decreasing
TG_(54:4) 14,200 ± 10,600 6230 ± 2180 3450 ± 1230 977 ± 444 y = −1570x + 18,200 * 0.91 Decreasing
TG_(54:5)26,100 ± 21,10010,200 ± 40504300 ± 13501010 ± 595y = −3010x + 33,4000.89Decreasing
TG_(54:6)24,900 ± 20,3009310 ± 32802980 ± 1090554 ± 426y = −2940x + 31,9000.88Decreasing
TG_(55:2)13.8 ± 4.819.88 ± 6.3816.2 ± 17.28.35 ± 3.23y = −0.371x + 14.90.13
TG_(55:3) 77.5 ± 39.7 46.2 ± 18.2 44.1 ± 29.4 19.7 ± 8.29 y = −6.5x + 96.6 * 0.91 Decreasing
TG_(55:4) 142 ± 102 65.1 ± 25.8 44.9 ± 20.2 10.8 ± 6.06 y = −15.3x + 183 * 0.92 Decreasing
TG_(55:5) 161 ± 137 92.4 ± 44 49.8 ± 23.4 14.4 ± 11 y = −17.9x + 216 * 0.98 Decreasing
TG_(55:6) 122 ± 143 100 ± 46.1 50.3 ± 18.8 8.95 ± 8.19 y = −14.4x + 180 * 0.98 Decreasing
TG_(56:2)31.6 ± 11.620.8 ± 10.430.9 ± 4011.7 ± 4.55y = −1.84x + 37.80.46
TG_(56:3) 189 ± 87.4 100 ± 43.6 93.3 ± 74.8 31.4 ± 14.6 y = −17.8x + 239 * 0.91 Decreasing
TG_(56:6) 6970 ± 6060 3330 ± 1460 1200 ± 414 246 ± 173 y = −826x + 9260 * 0.93 Decreasing
TG_(56:7) 8570 ± 7750 3690 ± 1650 1190 ± 519 282 ± 194 y = −1010x + 11,200 * 0.90 Decreasing
TG_(56:8)7360 ± 76002990 ± 1460893 ± 372186 ± 119y = −875x + 95500.89Decreasing
TG_(57:2)0.611 ± 0.4050.434 ± 0.6011 ± 1.890.371 ± 0.399y = −0.0057x + 0.6480.00
TG_(57:6) 83.1 ± 100 39.6 ± 24.4 16.6 ± 3.26 5.21 ± 5.03 y = −9.51x + 109 * 0.93 Decreasing
TG_(58:10)1370 ± 1470564 ± 268161 ± 77.329.9 ± 23.1y = −164x + 17800.90Decreasing
TG_(58:7)1160 ± 1150484 ± 241123 ± 65.220 ± 18.1y = −140x + 15200.90Decreasing
TG_(58:8)1600 ± 1440654 ± 354186 ± 77.942.6 ± 30.7y = −190x + 20800.89Decreasing
TG_(58:9)1730 ± 1730730 ± 418206 ± 10641.2 ± 28.3y = −207x + 22600.90Decreasing
TG_(59:3)0.283 ± 0.2730.333 ± 0.7080.539 ± 1.260.0277 ± 0.0537y = −0.0207x + 0.4540.12
TG_(59:4)0.348 ± 0.4740.22 ± 0.4490.372 ± 0.8070.00429 ± 0.0121y = −0.0326x + 0.4850.45
TG_(59:5)0.212 ± 0.2410.104 ± 0.128ND ± NDND ± NDy = −0.04x + 0.3561.00
TG_(59:6)0.382 ± 0.5780.178 ± 0.2270.137 ± 0.1740.108 ± 0.197y = −0.032x + 0.4460.81Decreasing
TG_(59:7)0.214 ± 0.4340.147 ± 0.232ND ± ND0.0326 ± 0.0607y = −0.0222x + 0.2911.00
TG_(59:8) 9.09 ± 14.6 6.77 ± 11.9 5.83 ± 9.99 1.75 ± 2.04 y = −0.85x + 12.4 * 0.94 Decreasing
TG_(60:10)194 ± 19473.7 ± 56.64.21 ± 4.150.838 ± 1.23y = −24x + 2520.86Decreasing
TG_(60:12) 79.5 ± 74.4 39.6 ± 28 13 ± 12.1 1.42 ± 2.02 y = −9.66x + 107 * 0.94 Decreasing
TG_(62:12) 63.3 ± 43.7 31.3 ± 17.4 11 ± 5.05 0.863 ± 0.716 y = −7.69x + 85.4 * 0.95 Decreasing
TG_(62:13) 4.22 ± 2.92 2.86 ± 3.13 0.546 ± 1.15 0.0336 ± 0.0949 y = −0.551x + 6.13 * 0.95 Decreasing

3. Discussion

Out of 472 lipids detected and semi-quantified, 100 showed a strong relationship with the dietary intake of ruminant fat with 35 species increasing and 65 species decreasing as the percentage of ruminant fat in the diet increased (NB. ruminant fat as a percentage composition with corn-oil and medium chain triacylglyceride oil). Interestingly, ceramides generally increased, whilst cardiolipins, sphingomyelins and triacylglycerides generally decreased as the dietary composition of ruminant fat rose. According to the literature, a rise in liver ceramides is typically associated with aggravated non-alcoholic fatty liver disease (NAFLD) and insulin resistance [23], this in conjunction with a decrease in cardiolipins (which are indicative of mitochondrial remodelling and dysfunction [24]) may suggest that the changes in the experimental diets here are detrimental for these pathologies. However, there was a clear decrease in the triacylglycerides (particularly evident in the unsaturated odd chain triacylglycerides), which is explicitly representative of an ameliorated pathology [25]. As previously published [26], many NAFLD and insulin resistance factors were mitigated as the ruminant fat increased in these diets, including: a reduction in the total body weight (g), total fat mass (%), serum ALT (U/mL) and degree of steatosis determined by Oil Red O staining, notably, the inflammatory marker TNFα did not change significantly (trend: p-value = 0.52). A key characteristic of NAFLD development is the accumulation of hepatic triacylglycerides [27]; therefore, the data here suggests that these dietary changes may be beneficial for NAFLD and insulin resistance by aiding in a reduced hepatic triacylglyceride load: possible mechanisms here include a lower saturated fatty acid composition resulting in a lower fatty acid incorporation into hepatic triacylglycerides and/or a higher pass-through of the medium chain triglyceride oil directly into the mitochondria stimulation fatty acid metabolism [26]. Work presented by Gonzalez-Cantero and colleagues [28] showed that hepatic triacylglyceride content were correlated with insulin resistance and these relationships were independently to the inflammatory marker TNFα. Therefore, it appears that the hepatic triacylglyceride load may be paramount in the development of NAFLD and insulin resistance, which is supported in the literature [29]. According to the literature, odd chain fatty acids are considered biomarkers of their dietary intake and particularly accredited as a biomarkers of ruminant fat intake (e.g., milk, butter and beef tallow, etc.); however, there is a vast amount of conflicting data [2]. Some studies have shown both positive correlations (either individual odd chain lipids or total odd chain lipids) and some studies have shown there were no significant correlations. Although these studies may conflict in their findings they all present their data as relative compositions (Mol%), which is the typical way lipid data appear in the literature [30]. By expressing the lipid data as relative compositions (Mol%), it normalises the data to the total fat in that sample; however, presenting the lipid data in this way confounds the results by interconnecting the individual data points. This interconnection can cause false positive and/or false negative conclusions (type 1 and 2 errors), i.e., if a single lipid increases it will artificially decrease the other(s) due to the Mol% calculation. As shown in the figure below (see Figure 2), the concentration of the total lipids containing either even chain or odd chain fatty acids and a combination are shown. Although lipids containing odd chain fatty acids did increase, albeit not statistically significantly; p-value: 0.197, it was also not proportionate to the increase in dietary ruminant fat. As shown, the lipids containing even chain fatty acids did significantly inversely decrease (slope p-value: 0.0189) as the dietary ruminant fat increased. Interestingly, due to both the decrease in the even chain lipids and the consistency of the odd chain lipids, if the relative composition (Mol%) of the lipids were calculated, there appears to be a statistically significant increase in the odd chain lipids (see Figure 3); however, this is an artefact of changes in the even chain lipids and a consequence of interconnecting the data.
Figure 2

This figure shows the change in the liver lipid concentrations across the four high-fat diets fed to Sprague–Dawley rats (n = 8–9 per group): total odd chain lipids (symbol: X, trendline: , gradient: 0.183 ± 0.0962, R2 = 0.64, slope significance p-value: 0.197); total even chain lipids (symbol: , trendline: , gradient: −41.0 ± 5.71, R2 = 0.963, slope significance p-value: 0.0189); total lipids containing both even and of odd chain (symbol: O, trendline: , gradient: −40.8 ± 5.79, R2 = 0.961, slope significance p-value: 0.0195. Lipid concentrations (µM/mg) are shown as means ± standard deviation and were extracted via the protein precipitation liquid extraction protocol (chloroform: methanol: acetone, ~7:3:4).

Figure 3

This figure shows the relative compositional (Mol%) change in the total odd chain lipids (symbol: X, trendline: , gradient: 0.0604 ± 0.00203, R2 = 0.998, slope significance p-value: 0.0011) and the total even chain lipids (symbol: , trendline: , gradient: −0.0604 ± 0.00203, R2 = 0.998, slope significance p-value: 0.0011) across the four high-fat diets in Sprague–Dawley rats (n = 8–9 per group). Lipid compositions (Mol%) are shown as means ± standard deviation and were extracted via the protein precipitation liquid extraction protocol (chloroform: methanol: acetone, ~7:3:4). Diet one: 3.6% beef tallow; diet two: 6.3% beef tallow; diet three: 9.0% beef tallow; diet four: 11.7% beef tallow.

4. Materials and Methods

4.1. Chemicals and Standards

Stable isotope-labelled internal standards purchased from Sigma Aldrich (Haverhill, Suffolk, UK) include: N-palmitoyl-d31-D-erythro-sphingosine (abbreviated to IS_Cer_16:0-d31); order number: 868516P, 1-palmitoyl-d31-2-oleoyl-sn-glycero-3-phosphate (abbreviated to IS_PA_34:1-d31); order number: 860453P, 1-palmitoyl-d31-2-oleoyl-sn-glycero-3-phosphocholine (abbreviated to IS_PC_34:1-d31); order number: 860399P, 1-palmitoyl-d31-2-oleoyl-sn-glycero-3-phosphoethanolamine (abbreviated to IS_PE_34:1-d31); order number: 860374P, 1-palmitoyl-d31-2-oleoyl-sn-glycero-3-[phospho-rac-(1-glycerol)] (abbreviated to IS_PG_34:1-d31); order number: 860384P, 1-palmitoyl-d31-2-oleoyl-sn-glycero-3-phosphoinositol (abbreviated to IS_PI_34:1-d31); order number: 860042P, 1,2-dimyristoyl-d54-sn-glycero-3-[phospho-L-serine] (abbreviated to IS_PS_28:0-d54); order number: 860401P, N-palmitoyl-d31-D-erythro-sphingosylphosphorylcholine (abbreviated to IS_SM_34:1-d31); order number: 868584P. Stable isotope-labelled internal standards purchased from QMX Laboratories Ltd. (QMX Laboratories Ltd., Thaxted, Essex, UK) include: Heptadecanoic-d33 acid (abbreviated to IS_FA_17:0-d33); order number: D-5261, N-tetradecylphosphocholine-d42 (abbreviated to IS_LPC_14:0-d42); order number: D-5885, Glyceryl tri(pentadecanoate-d29) (abbreviated to IS_TG_45:0-d87); order number: D-5265, Butyryl-d7-L-carnitine (abbreviated to IS_Car_4:0-d7); order number: D-7761, Hexadecanoyl-L-carnitine-d3 (abbreviated to IS_Car_16:0-d3); order number: D-6646. Quality control standards (LIPID-QC) purchased from Cayman Chemical Company (Cambridge Bioscience, Cambridge, UK) include: Lysophosphatidylcholines (egg); order number: 24331, Phosphotidylcholines (egg); order number: 24343, Lysophosphatidylethanolamines (egg); order number: 25844, Phosphatidylethanolamines (bovine); order number: 16878, Phosphotidlethanolamine (soy); order number: 25845, Lysophosphatidyinositols (porcine liver); order number: 26016, Phosphatidylserines (soy); order number: 25847, Ceramides mixture; order number: 22853, Ceramides (non-hydroxy); order number: 24833, Ceramides (hydroxy); order number: 24834, Sphingomyelins (from bovine spinal cord); order number: 22674, Sphingomylins (egg); order number: 24345, Phosphatidylglycerols (egg); order number: 25846, Phosphatidic acid (egg); order number: 24344, Sulfatides (bovine); order number: 24323, Purified mixed gangliosides (bovine); order number: 24856, TLC Neutral Glycosphingolipid Mixture (bovine and porcine); order number: 1505, 2-Palmitoyl Glycerol; order number: CAY17882, 1,2-Dipalmitoyl-sn-glycerol; order number: CAY10008648. Quality control standards purchased from Sigma Aldrich include: Soy PC (95%); order number: 441601G, C18(Plasm)-18:1-PC; order number: 852467C, Brain CPE; order number: 860066P, Liver PI; order number: 840042P, Brain lyso PS; order number: 850092P, Milk SM Sphingomyelin (Milk, Bovine); order number: 860063P, Galactocerebrosides from bovine brain; order number: C4905, Glucosylceramide (Soy); order number: 131304P, Triglyceride mix, C2–C10; order number: 17810-1amp-s, Fish oil from menhaden; order number: F8020, Anhydrous butter fat, Cardiolipin solution from bovine heart; order number: C1649, Brain PI(4)P; order number: 840045P. Commercially available blank human serum was purchased from BioIVT (Royston, Hertfordshire, UK; order number: HUMANSRMPNN. All solvents and additives were of HPLC grade or higher and purchased from Sigma Aldrich unless otherwise stated. LIPID-IS: the lipid stable isotope-labelled internal standard was prepared by dissolving each of the individual lipid standards into chloroform: methanol (1:1) solution to produce a 1 mM primary stock solution. From each of these stock solutions, 1 mL was transferred into a volumetric flask and diluted with methanol to reach a final working solution concentration of 5 µM in methanol of IS_Cer_16:0-d31, IS_FA_17:0-d33, IS_LPC_14:0-d42, IS_PA_34:1-d31, IS_PC_34:1-d31, IS_PE_34:1-d31, IS_PG_34:1-d31, IS_PI_34:1-d31, IS_PS_28:0-d54, IS_SM_34:1-d31, IS_TG_45:0-d87. ACYL-CARNITINE-IS: the acyl-carnitine stable isotope-labelled internal standard was prepared by dissolving each powdered stock into methanol to achieve a 5 mM stock solution. Taking 1 mL of the IS_Car_4:0-d7 and IS_Car_16:0-d3 stock solutions and diluting these into methanol until a final working solution of 5 µM was achieved for IS_Car_4:0-d7 and IS_Car_16:0-d3. LIPID-QC: the lipid quality control standards were prepared by diluting each lipid mix to achieve a 50 µg/mL working stock solution in propan-2-ol: acetonitrile: water (2:1:1, respectively).

4.2. Extraction

Lipids were isolated comparing two methods; firstly, a novel protein-precipitation liquid extraction and secondly the liquid–liquid extraction previously described by Folch and colleagues [12] in an adapted version as we described previously [31]. Tissue quantities ranged from ~2–50 mg and fluid samples from 10–50 µL (e.g., plasma/serum) were tested (data not shown here).

4.2.1. Protein Precipitation Liquid Extraction Protocol (PPLE)

The protein-precipitation liquid extraction protocol was as follows: the tissue samples were weighed (NB. fluid samples were pipetted) and transferred into a 2 mL screw cap Eppendorf plastic tube (Eppendorf, Stevenage, UK) along with a single 5 mm stainless steel ball bearing. Immediately, 400 µL of chloroform: methanol (2:1, respectively) solution was added to each sample, followed by thorough mixing. The samples were then homogenised in the chloroform: methanol (2:1, respectively) using a Bioprep 24-1004 homogenizer (Allsheng, Hangzhou, China) run at speed; 4.5 m/s, time; 30 s for 2 cycles. Then, 400 µL of chloroform, 100 µL of the LIPID-IS (5 µM in methanol) and 100 µL of the CARNITINE-IS (5 µM in methanol) was added to each sample. The samples were homogenised again using a Bioprep 24-1004 homogenizer run at speed; 4.5 m/s, time; 30 s for 2 cycles. To ensure fibrous material was diminished, the samples were sonicated for 30 min in a water bath sonicator (Advantage-Lab, Menen, Belgium). Then, 400 µL of acetone was added to each sample. The samples were thoroughly vortexed and centrifuged for 10 min at ~20,000× g to pellet any insoluble material at the bottom of the vial. The single layer supernatant was pipetted into separate 2 mL screw cap amber-glass auto-sampler vials (Agilent Technologies, Cheadle, UK); being careful not to break up the solid pellet at the bottom of the tube. The organic extracts (chloroform, methanol, acetone composition, ~1.4 mL) were dried down to dryness using a Concentrator Plus system (Eppendorf, Stevenage, UK) run for 60 min at 60 °C. The samples were reconstituted in 100 µL of 2:1:1 (propan-2-ol, acetonitrile and water, respectively) then thoroughly vortex. The reconstituted sample was transferred into a 250 μL low-volume vial insert inside a 2 mL amber glass auto-sample vial ready for liquid chromatography with mass spectrometry detection (LC–MS) analysis.

4.2.2. Folch Liquid–Liquid Extraction Protocol (Folch LLE)

The Folch liquid–liquid extraction protocol is as follows: the tissue samples were weighed (NB. fluid samples were pipetted) and transferred into a 2 mL screw cap Eppendorf plastic tube (Eppendorf, Stevenage, UK) along with a single 5 mm stainless steel ball bearing. Immediately, 400 µL of chloroform: methanol (2:1, respectively) solution was added to each sample, followed by thorough mixing. The samples were then homogenised in the chloroform: methanol (2:1, respectively) using a Bioprep 24-1004 homogenizer (Allsheng, Hangzhou, China) run at speed; 4.5 m/s, time; 30 s for 2 cycles. Then, 400 µL of chloroform, 100 µL of the LIPID-IS (5 µM in methanol) and 100 µL of the ACYL-CARNITINE-IS (5 µM in methanol) was added to each sample. The samples were homogenised again using a Bioprep 24-1004 homogenizer run at speed; 4.5 m/s, time; 30 s for 2 cycles. To ensure fibrous material was diminished, the samples were sonicated for 30 min in a water bath sonicator. Then, 400 µL of HPLC water was added to each samples. The samples were thoroughly vortexed and centrifuged for 10 min at ~20,000 g to separate the two immiscible fractions. The organic fractions (the lower layer, mostly chloroform; ~700 µL) and aqueous fractions (the upper layer, methanol and water; ~700 µL) were pipetted into separate 2 mL screw cap amber-glass auto-sampler vials (Agilent Technologies, Cheadle, UK); being careful not to break up the solid pellet between the layers. To ensure complete lipid isolation a double extraction protocol was followed; 1 mL of chloroform: methanol (2:1, respectively) solution was added to each sample, along with 400 µL of HPLC water. The samples were thoroughly vortexed and centrifuged for 10 min at ~20,000× g. The organic fractions and aqueous fractions were pipetted into the corresponding 2 mL screw cap amber-glass auto-sampler vials containing the initial extracts (again being careful not to break up the solid pellet between the layers). The combined organic extracts (~1.4 mL) were dried down to dryness using a Concentrator Plus system (Eppendorf, Stevenage, UK) run for 60 min at 60 °C. The samples were reconstituted in 100 µL of 2:1:1 (propan-2-ol, acetonitrile and water, respectively) then thoroughly vortex. The reconstituted sample was transferred into a 250 μL low-volume vial insert inside a 2 mL amber glass auto-sample vial ready for liquid chromatography with mass spectrometry detection (LC–MS) lipidomics analysis.

4.3. LC–MS Method

Full chromatographic separation of intact lipids was achieved using a Shimadzu HPLC System (Shimadzu UK Limited, Milton Keynes, UK) with the injection of 10 µL onto a Waters Acquity UPLC® CSH C18 column (Waters, Hertfordshire, UK); 1.7 µm, I.D. 2.1 mm × 50 mm, maintained at 55 °C. Mobile phase A was 6:4, acetonitrile and water with 10 mM ammonium formate. Mobile phase B was 9:1, propan-2-ol and acetonitrile with 10 mM ammonium formate. The flow was maintained at 500 µL per minute through the following gradient: 0.00 min_40% mobile phase B; 0.40 min_43% mobile phase B; 0.45 min_50% mobile phase B; 2.40 min_54% mobile phase B; 2.45 min_70% mobile phase B; 7.00 min_99% mobile phase B; 8.00 min_99% mobile phase B; 8.3 min_40% mobile phase B; 10 min_40% mobile phase B. The sample injection needle was washed using 9:1, 2-propan-2-ol and acetonitrile. The mass spectrometer used was the Thermo Scientific Exactive Orbitrap with a heated electrospray ionisation source (Thermo Fisher Scientific, Hemel Hempstead, UK). The mass spectrometer was calibrated immediately before sample analysis using positive and negative ionisation calibration solution (recommended by Thermo Scientific). Additionally, the heated electrospray ionisation source was optimised at 50:50 mobile phase A to mobile phase B for spray stability (capillary temperature; 300 °C, source heater temperature; 420 °C, sheath gas flow; 40 (arbitrary), auxiliary gas flow; 15 (arbitrary), spare gas; 3 (arbitrary), source voltage; 4 kV. The mass spectrometer scan rate set at 4 Hz, giving a resolution of 25,000 (at 200 m/z) with a full-scan range of m/z 100 to 1800 with continuous switching between positive and negative mode.

4.4. Data Processing

Thermo Xcalibur Quan Browser (Thermo Fisher Scientific, Hemel Hempstead, UK) data processing involved the integration of the internal standard extracted ion chromatogram (EIC) peaks at the expected retention times (see Table 2). The EIC were selected from the ionisation mode for each analyte class; the ionisation mode is dependent on the molecular chemistry of the analytes, i.e., basic chemical groups ordinarily result in positive ionisation (e.g., [M+H]+, M+H-H2O]+, [M+Na]+, [M+NH4]+, [M+K]+) whereas acidic chemical groups typically result in negative ionisation (e.g., [M-H]−).
Table 2

This table shows the stable isotope-labelled internal standards with their ionisation products (i.e., [M+H]+, M+H-H2O]+, [M+Na]+, [M+NH4]+, [M+K]+, [M-H]−) and primary ionisation mode (positive; +ve or negative; −ve), along with their retention time (minutes). Butyryl-d7-L-carnitine (abbreviated to IS_Car_4:0-d7), N-tetradecylphosphocholine-d42 (abbreviated to IS_LPC_14:0-d42), hexadecanoyl-L-carnitine-d3 (abbreviated to IS_Car_16:0-d3), heptadecanoic-d33 acid (abbreviated to IS_FA_17:0-d33), 1,2-dimyristoyl-d54-sn-glycero-3-[phospho-L-serine] (abbreviated to IS_PS_28:0-d54), 1-palmitoyl-d31-2-oleoyl-sn-glycero-3-phosphoinositol (abbreviated to IS_PI_34:1-d31), N-palmitoyl-d31-D-erythro-sphingosylphosphorylcholine (abbreviated to IS_SM_34:1-d31), 1-palmitoyl-d31-2-oleoyl-sn-glycero-3-[phospho-rac-(1-glycerol)] (abbreviated to IS_PG_34:1-d31), 1-palmitoyl-d31-2-oleoyl-sn-glycero-3-phosphate (abbreviated to IS_PA_34:1-d31), N-palmitoyl-d31-D-erythro-sphingosine (abbreviated to IS_Cer_16:0-d31), 1-palmitoyl-d31-2-oleoyl-sn-glycero-3-phosphocholine (abbreviated to IS_PC_34:1-d31), 1-palmitoyl-d31-2-oleoyl-sn-glycero-3-phosphoethanolamine (abbreviated to IS_PE_34:1-d31), glyceryl tri(pentadecanoate-d29) (abbreviated to IS_TG_45:0-d87).

Internal StandardIonisation Product (m/z)Ionisation ModeExpected Retention Time (mins)
IS_Car_4:0-d7239.1983+ve0.3
IS_LPC_14:0-d42422.5560, 421.5498, 420.5435+ve0.4
IS_Car_16:0-d3403.3610+ve0.5
IS_FA_17:0-d33302.4557, 301.4495, 300.4432−ve1.1
IS_PS_28:0-d54732.7741, 731.7678, 730.7615, 729.7553, 728.7490−ve1.4
IS_PI_34:1-d31864.7162, 865.7225, 866.7288−ve2.9
IS_SM_34:1-d31733.7632, 734.7670, 755.7451, 756.7514, 771.7190, 772.7253+ve3.0
IS_PG_34:1-d31775.6939, 776.7002, 777.7065, 778.7127−ve3.0
IS_PA_34:1-d31700.6509, 701.6571, 702.6634, 703.6697, 704.6760−ve3.4
IS_Cer_16:0-d31548.6851, 549.6914, 550.6977, 551.7039, 566.6951, 567.7014, 568.7076, 569.7139, 590.6896, 591.6959, 606.6636, 607.6698+ve3.9
IS_PC_34:1-d31790.7700, 791.7750, 812.7553, 813.7616, 828.7292, 829.7355+ve3.9
IS_PE_34:1-d31747.7181, 748.7254, 749.7327, 769.7021, 770.7084, 771.7146, 785.6760, 786.6823, 787.6886+ve4.0
IS_TG_45:0-d87850.2239, 851.2301, 852.2364, 853.2427, 867.2504, 868.2567, 869.2630, 870.2693, 872.2059, 873.2121, 874.2184, 875.2247, 888.1798, 889.1861, 890.1923, 891.1986+ve5.8
As shown in the table above (see Table 2), the internal standards have multiple ionisation products, these are the result of numerous ionisation mechanism (for example IS_TG_45:0-d87 having different adducts: [M+H]+, [M+Na]+, [M+K]+ and [M+NH4]+, present) as well as an isotopic distribution (e.g., IS_TG_45:0-d87 having either the expected eighty-seven or fewer deuterium atoms present) all reasonably expected ions were included into the EIC for each internal standard (see Figure 4).
Figure 4

This figure shows a spiked (5 µM in methanol) commercial human plasma extracted ion chromatogram (EIC) for the stable isotope-labelled internal standards (lipids and acyl-carnitines): butyryl-d7-L-carnitine (abbreviated to IS_Car_4:0-d7); area ~5.9 × 106 counts, N-tetradecylphosphocholine-d42 (abbreviated to IS_LPC_14:0-d42); are ~2.1 × 108 counts, hexadecanoyl-L-carnitine-d3 (abbreviated to IS_Car_16:0-d3); area ~5.8 × 108 counts, heptadecanoic-d33 acid (abbreviated to IS_FA_17:0-d33); area ~1.1 × 104 counts, 1,2-dimyristoyl-d54-sn-glycero-3-[phospho-L-serine] (abbreviated to IS_PS_28:0-d54); area ~2.2 × 107 counts, 1-palmitoyl-d31-2-oleoyl-sn-glycero-3-phosphoinositol (abbreviated to IS_PI_34:1-d31): area ~1.1 × 107 counts, N-palmitoyl-d31-D-erythro-sphingosylphosphorylcholine (abbreviated to IS_SM_34:1-d31); 1.4 × 108 counts, 1-palmitoyl-d31-2-oleoyl-sn-glycero-3-[phospho-rac-(1-glycerol)] (abbreviated to IS_PG_34:1-d31); area ~6.1 × 107 counts, 1-palmitoyl-d31-2-oleoyl-sn-glycero-3-phosphate (abbreviated to IS_PA_34:1-d31); area ~1.3 × 107 counts, N-palmitoyl-d31-D-erythro-sphingosine (abbreviated to IS_Cer_16:0-d31); area ~2.2 × 108 counts, 1-palmitoyl-d31-2-oleoyl-sn-glycero-3-phosphocholine (abbreviated to IS_PC_34:1-d31); area ~2.5 × 108 counts, 1-palmitoyl-d31-2-oleoyl-sn-glycero-3-phosphoethanolamine (abbreviated to IS_PE_34:1-d31); area ~6.3 × 107 counts, glyceryl tri(pentadecanoate-d29) (abbreviated to IS_TG_45:0-d87); area ~3.2 × 107 counts.

The adduct composition of the total EIC produced from each of the ionisation mechanisms are shown in the figure below (see Figure 5).
Figure 5

This figure shows the intensity of the extracted ion chromatogram for each stable isotope-labelled internal standard along with the ionisation adduct composition: [M+H]+, [M+H-H2O]+, [M+NH4]+, [M+Na]+, [M+K]+ and [M-H]−. Butyryl-d7-L-carnitine (abbreviated to IS_Car_4:0-d7), N-tetradecylphosphocholine-d42 (abbreviated to IS_LPC_14:0-d42), hexadecanoyl-L-carnitine-d3 (abbreviated to IS_Car_16:0-d3), heptadecanoic-d33 acid (abbreviated to IS_FA_17:0-d33), 1,2-dimyristoyl-d54-sn-glycero-3-[phospho-L-serine] (abbreviated to IS_PS_28:0-d54), 1-palmitoyl-d31-2-oleoyl-sn-glycero-3-phosphoinositol (abbreviated to IS_PI_34:1-d31), N-palmitoyl-d31-D-erythro-sphingosylphosphorylcholine (abbreviated to IS_SM_34:1-d31), 1-palmitoyl-d31-2-oleoyl-sn-glycero-3-[phospho-rac-(1-glycerol)] (abbreviated to IS_PG_34:1-d31), 1-palmitoyl-d31-2-oleoyl-sn-glycero-3-phosphate (abbreviated to IS_PA_34:1-d31), N-palmitoyl-d31-D-erythro-sphingosine (abbreviated to IS_Cer_16:0-d31), 1-palmitoyl-d31-2-oleoyl-sn-glycero-3-phosphocholine (abbreviated to IS_PC_34:1-d31), 1-palmitoyl-d31-2-oleoyl-sn-glycero-3-phosphoethanolamine (abbreviated to IS_PE_34:1-d31), glyceryl tri(pentadecanoate-d29) (abbreviated to IS_TG_45:0-d87).

The data processing also involved the integration of the individual lipid (and derivatives) species at their expected retention time (see Supplementary Table S2) allowing for a maximum of ±0.1 min of retention time drift: any retention time drift greater than ±0.1 min resulted in the exclusion of the analyte leading to a ‘Not Found’ result (i.e., zero concentration). A list of the analyte classes along with the number of species detected within each class are shown in the table below (see Table 3). The expected adducts for each analyte class and the internal standard used for semi-quantitation are also shown.
Table 3

This table shows the lipid classes detected with this LC–MS lipidomics method. The number of species per lipid class and the measured adducts (protonated: [M+H]+, deprotonated: [M-H]−, protonated with water loss: [M+H-H2O]+, sodiated: [M+Na]+, potasiated: [M+K]+, ammoniated: [M+NH4]+) are also shown. The internal standard used for semi-quantification are also shown: butyryl-d7-L-carnitine (abbreviated to IS_Car_4:0-d7), N-tetradecylphosphocholine-d42 (abbreviated to IS_LPC_14:0-d42), hexadecanoyl-L-carnitine-d3 (abbreviated to IS_Car_16:0-d3), heptadecanoic-d33 acid (abbreviated to IS_FA_17:0-d33), 1,2-dimyristoyl-d54-sn-glycero-3-[phospho-L-serine] (abbreviated to IS_PS_28:0-d54), 1-palmitoyl-d31-2-oleoyl-sn-glycero-3-phosphoinositol (abbreviated to IS_PI_34:1-d31), N-palmitoyl-d31-D-erythro-sphingosylphosphorylcholine (abbreviated to IS_SM_34:1-d31), 1-palmitoyl-d31-2-oleoyl-sn-glycero-3-[phospho-rac-(1-glycerol)] (abbreviated to IS_PG_34:1-d31), 1-palmitoyl-d31-2-oleoyl-sn-glycero-3-phosphate (abbreviated to IS_PA_34:1-d31), N-palmitoyl-d31-D-erythro-sphingosine (abbreviated to IS_Cer_16:0-d31), 1-palmitoyl-d31-2-oleoyl-sn-glycero-3-phosphocholine (abbreviated to IS_PC_34:1-d31), 1-palmitoyl-d31-2-oleoyl-sn-glycero-3-phosphoethanolamine (abbreviated to IS_PE_34:1-d31), glyceryl tri(pentadecanoate-d29) (abbreviated to IS_TG_45:0-d87).

Analyte ClassNo. of SpeciesAdductsInternal Standard
Acyl-carnitines48[M+H]+IS_Car_4:0-d7, IS_Car_16:0-d3
Ceramides85[M+H]+, [M+H-H2O]+IS_Cer_16:0-d31
Cardiolipins56[M-H]IS_TG_45:0-d87
Diacylglycerols6[M+H-H2O]+, [M+Na]+, [M+K]+IS_TG_45:0-d87
Gangliosides (GM1)24[M-H]IS_PG_34:1-d31
Hexosylceramides56[M+H]+, [M+H-H2O]+IS_Cer_16:0-d31
Lyso-phosphatidylcholines23[M+H]+IS_LPC_14:0-d42
Lyso-phosphatidyethanolamines19[M+H]+IS_LPC_14:0-d42
Lyso-phosphatidylinositols19[M-H]IS_PI_34:1-d31
Lyso-phosphoserines20[M-H]IS_PS_28:0-d54
Lyso-cardiolipins23[M-H]IS_TG_45:0-d87
Monoacylglycerols1[M+H-H2O]+, [M+Na]+, [M+K]+IS_TG_45:0-d87
Phosphatidic acids26[M-H]IS_PA_34:1-d31
Phosphatidylcholines43[M+H]+IS_PC_34:1-d31
Phosphatidylethanolamines19[M+H]+IS_PE_34:1-d31
Phosphatidylglycerol34[M-H]IS_PG_34:1-d31
Phosphatidylinositols21[M-H]IS_PI_34:1-d31
Phosphatidylserines36[M-H]IS_PS_28:0-d54
Sulfatides72[M-H]IS_PG_34:1-d31
Sphingomyelins54[M+H]+, [M+Na]+, [M+K]+IS_SM_34:1-d31
Triacylglycerides89[M+H]+, [M+NH4]+, [M+Na]+, [M+K]+IS_TG_45:0-d87
The lipid quality control (QC) standards were analysed with each batch of samples, these QC standards were used to check the retention times for the analytes ensuring that isobaric analytes were separated and expected analyte retention times remained robust. Through the Thermo Xcalibur Quan Browser software, the responses of the analytes were normalised to the relevant internal standard response (producing area ratios) (see Supplementary Table S2), these area ratios corrected the intensity for any extraction and instrument variations. The area ratios were then blank corrected where intensities less than three times the blank samples were set to a ‘Not Found’ result (i.e., zero concentration). The accepted area ratios were then multiplied by the concentration of the internal standard to give the analyte concentrations. The results for fluid samples were expressed in molar concentrations (typically µM or nM). For tissue samples, the calculated concentrations of the analytes were then divided by the amount of tissue (in mg) used in the extraction protocol to give the final results in µM per mg of tissue extracted (µM/mg).

4.5. Animal Intervention

Sprague–Dawley rats (Harlan, IN, USA) were overfed using one of four experimental diets (n = 6–9 per group) at 17% above matched growth via an intragastric cannula surgically inserted as previously described [26]. Animals had ad libitum access to water throughout the experiments. The four experimental diets were 70% fat (% energy) including different amounts of medium chain triacylglycerides oil (MCT), beef tallow and corn oil; the fat composition of each diet are shown in the table below (see Table 4).
Table 4

This table shows the dietary fat composition of each of the four experimental diets fed to Sprague–Dawley rats (n = 8–9 per group). MCT: medium chain triglyceride oil.

DietCorn OilMCT OilBeef Tallow
150%16.4%3.6%
235%28.7%6.3%
320%41.0%9.0%
45%53.3%11.7%
Protein (19% whey protein), vitamin and mineral contents were the same in all diets. Diets were formulated to meet the caloric and nutritional recommendations established by the National Research Council (NRC), but were fed at a level that exceeded the recommended caloric intake by 17% to increase weight gain and adiposity and produce steatohepatitis. Liver tissue was collected after 21 days. All experimental procedures were ethically approved by the Institutional Animal Care and Use Committee at the University of Arkansas for Medical Science.

5. Conclusions

This lipidomics protocol has been developed to quantify lipids across a broad range of hydrophobicities, from acyl-carnitines through to long chain glycerolipids. The extraction method produces a single liquid supernatant phase ideal for high-throughput workflows with an increased extraction capability over the frequently published liquid–liquid extraction previously published by Folch and colleagues [12]. Following the establishment and validation of this method, we applied it to a ruminant fat dose response dietary intervention in Sprague–Dawley rats, where we found 100 lipid species correlated strongly with the composition of ruminant fat within the diet. It has been previously suggested that dietary ruminant fat is beneficial/protective in type 2 diabetes [32], the results presented in this manuscript suggest possible target mechanisms that need to be examined could include ceramide fatty acid compositions, cardiolipin remodeling, sphingomyelins and/or triacylglycerides concentration (particularly unsaturated odd chain species) and their associated fatty acid compositions, as well as the liver total lipid content.
  27 in total

1.  A simple method for the isolation and purification of total lipides from animal tissues.

Authors:  J FOLCH; M LEES; G H SLOANE STANLEY
Journal:  J Biol Chem       Date:  1957-05       Impact factor: 5.157

2.  A Robust Lipidomics Workflow for Mammalian Cells, Plasma, and Tissue Using Liquid-Chromatography High-Resolution Tandem Mass Spectrometry.

Authors:  Candice Z Ulmer; Rainey E Patterson; Jeremy P Koelmel; Timothy J Garrett; Richard A Yost
Journal:  Methods Mol Biol       Date:  2017

Review 3.  Regulation of energy metabolism by long-chain fatty acids.

Authors:  Manabu T Nakamura; Barbara E Yudell; Juan J Loor
Journal:  Prog Lipid Res       Date:  2013-12-18       Impact factor: 16.195

Review 4.  Lipotoxicity in nonalcoholic fatty liver disease: not all lipids are created equal.

Authors:  Naim Alkhouri; Laura J Dixon; Ariel E Feldstein
Journal:  Expert Rev Gastroenterol Hepatol       Date:  2009-08       Impact factor: 3.869

Review 5.  Understanding the diversity of membrane lipid composition.

Authors:  Takeshi Harayama; Howard Riezman
Journal:  Nat Rev Mol Cell Biol       Date:  2018-02-07       Impact factor: 94.444

6.  Differences in the prospective association between individual plasma phospholipid saturated fatty acids and incident type 2 diabetes: the EPIC-InterAct case-cohort study.

Authors:  Nita G Forouhi; Albert Koulman; Stephen J Sharp; Fumiaki Imamura; Janine Kröger; Matthias B Schulze; Francesca L Crowe; José María Huerta; Marcela Guevara; Joline W J Beulens; Geertruida J van Woudenbergh; Laura Wang; Keith Summerhill; Julian L Griffin; Edith J M Feskens; Pilar Amiano; Heiner Boeing; Françoise Clavel-Chapelon; Laureen Dartois; Guy Fagherazzi; Paul W Franks; Carlos Gonzalez; Marianne Uhre Jakobsen; Rudolf Kaaks; Timothy J Key; Kay-Tee Khaw; Tilman Kühn; Amalia Mattiello; Peter M Nilsson; Kim Overvad; Valeria Pala; Domenico Palli; J Ramón Quirós; Olov Rolandsson; Nina Roswall; Carlotta Sacerdote; María-José Sánchez; Nadia Slimani; Annemieke M W Spijkerman; Anne Tjonneland; Maria-José Tormo; Rosario Tumino; Daphne L van der A; Yvonne T van der Schouw; Claudia Langenberg; Elio Riboli; Nicholas J Wareham
Journal:  Lancet Diabetes Endocrinol       Date:  2014-08-05       Impact factor: 32.069

7.  Odd Chain Fatty Acids; New Insights of the Relationship Between the Gut Microbiota, Dietary Intake, Biosynthesis and Glucose Intolerance.

Authors:  Benjamin J Jenkins; Kevin Seyssel; Sally Chiu; Pin-Ho Pan; Shih-Yi Lin; Elizabeth Stanley; Zsuzsanna Ament; James A West; Keith Summerhill; Julian L Griffin; Walter Vetter; Kaija J Autio; Kalervo Hiltunen; Stéphane Hazebrouck; Renata Stepankova; Chun-Jung Chen; Maud Alligier; Martine Laville; Mary Moore; Guillaume Kraft; Alan Cherrington; Sarah King; Ronald M Krauss; Evelyn de Schryver; Paul P Van Veldhoven; Martin Ronis; Albert Koulman
Journal:  Sci Rep       Date:  2017-03-23       Impact factor: 4.379

Review 8.  A review of odd-chain fatty acid metabolism and the role of pentadecanoic Acid (c15:0) and heptadecanoic Acid (c17:0) in health and disease.

Authors:  Benjamin Jenkins; James A West; Albert Koulman
Journal:  Molecules       Date:  2015-01-30       Impact factor: 4.411

9.  One- vs two-phase extraction: re-evaluation of sample preparation procedures for untargeted lipidomics in plasma samples.

Authors:  Andres Gil; Wenxuan Zhang; Justina C Wolters; Hjalmar Permentier; Theo Boer; Peter Horvatovich; M Rebecca Heiner-Fokkema; Dirk-Jan Reijngoud; Rainer Bischoff
Journal:  Anal Bioanal Chem       Date:  2018-07-02       Impact factor: 4.142

10.  Peroxisome Proliferator-Activated Receptor γ2 Controls the Rate of Adipose Tissue Lipid Storage and Determines Metabolic Flexibility.

Authors:  Sam Virtue; Kasparas Petkevicius; José Maria Moreno-Navarrete; Benjamin Jenkins; Daniel Hart; Martin Dale; Albert Koulman; José Manuel Fernández-Real; Antonio Vidal-Puig
Journal:  Cell Rep       Date:  2018-08-21       Impact factor: 9.423

View more
  6 in total

1.  Protocol for rapid and accurate quantification of phospholipids in yeast and mammalian systems using LC-MS.

Authors:  Sen Yang; Jingyuan Xue; Cunqi Ye
Journal:  STAR Protoc       Date:  2022-10-13

2.  Impact of Metformin Treatment on Human Placental Energy Production and Oxidative Stress.

Authors:  Jane L Tarry-Adkins; India G Robinson; Rebecca M Reynolds; Irving L M H Aye; D Stephen Charnock-Jones; Benjamin Jenkins; Albert Koulmann; Susan E Ozanne; Catherine E Aiken
Journal:  Front Cell Dev Biol       Date:  2022-06-17

3.  Metabolomics in early life and the association with body composition at age 2 years.

Authors:  Inge A L P van Beijsterveldt; Stuart G Snowden; Pernille Neve Myers; Kirsten S de Fluiter; Bert van de Heijning; Susanne Brix; Ken K Ong; David B Dunger; Anita C S Hokken-Koelega; Albert Koulman
Journal:  Pediatr Obes       Date:  2021-10-13       Impact factor: 3.910

4.  Comparison of the Lipidomic Signature of Fatty Liver in Children and Adults: A Cross-Sectional Study.

Authors:  Jake P Mann; Benjamin Jenkins; Samuel Furse; Stuart G Snowden; Anna Alisi; Laura G Draijer; Kylie Karnebeek; Deirdre A Kelly; Bart G Koot; Antonella Mosca; Camilla Salvestrini; Indra van Mourik; Anita Vreugdenhil; Matthias Zilbauer; Albert Koulman
Journal:  J Pediatr Gastroenterol Nutr       Date:  2022-02-19       Impact factor: 3.288

5.  Maternal but not fetoplacental health can be improved by metformin in a murine diet-induced model of maternal obesity and glucose intolerance.

Authors:  Antonia Hufnagel; Denise S Fernandez-Twinn; Heather L Blackmore; Thomas J Ashmore; Robert A Heaton; Benjamin Jenkins; Albert Koulman; Iain P Hargreaves; Catherine E Aiken; Susan E Ozanne
Journal:  J Physiol       Date:  2021-09-29       Impact factor: 6.228

6.  Inhibition of mitochondrial function by metformin increases glucose uptake, glycolysis and GDF-15 release from intestinal cells.

Authors:  Ming Yang; Tamana Darwish; Pierre Larraufie; Debra Rimmington; Irene Cimino; Deborah A Goldspink; Benjamin Jenkins; Albert Koulman; Cheryl A Brighton; Marcella Ma; Brian Y H Lam; Anthony P Coll; Stephen O'Rahilly; Frank Reimann; Fiona M Gribble
Journal:  Sci Rep       Date:  2021-01-28       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.